URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-p...
Submission: On March 14 via manual from US — Scanned from GB

Summary

This website contacted 23 IPs in 4 countries across 15 domains to perform 89 HTTP transactions. The main IP is 5.134.13.35, located in United Kingdom and belongs to UKNOC-AS, GB. The main domain is tumor-myeloid-therapeutics.com.
TLS certificate: Issued by R3 on February 1st 2024. Valid for: 3 months.
This is the only time tumor-myeloid-therapeutics.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
26 5.134.13.35 34282 (UKNOC-AS)
1 2400:52e0:1e0... 200325 (BUNNYCDN)
2 2a00:1450:400... 15169 (GOOGLE)
2 2a00:1450:400... 15169 (GOOGLE)
2 2400:52e0:1e0... 200325 (BUNNYCDN)
3 2a00:1450:400... 15169 (GOOGLE)
4 2606:4700:20:... 13335 (CLOUDFLAR...)
8 188.166.193.169 14061 (DIGITALOC...)
7 2400:52e0:1e0... 200325 (BUNNYCDN)
1 2606:4700:20:... 13335 (CLOUDFLAR...)
1 65.9.66.43 16509 (AMAZON-02)
2 2a00:1450:400... 15169 (GOOGLE)
11 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
2 34.117.177.207 396982 (GOOGLE-CL...)
1 35.71.131.137 16509 (AMAZON-02)
1 2606:4700::68... 13335 (CLOUDFLAR...)
2 34.237.219.119 14618 (AMAZON-AES)
1 3.215.172.219 14618 (AMAZON-AES)
1 2a00:1450:400... 15169 (GOOGLE)
5 2a00:1450:400... ()
89 23
Apex Domain
Subdomains
Transfer
24 tumor-myeloid-therapeutics.com
tumor-myeloid-therapeutics.com
505 KB
20 optimonk.com
onsite.optimonk.com — Cisco Umbrella Rank: 39076
cdn-account.optimonk.com — Cisco Umbrella Rank: 39328
front.optimonk.com — Cisco Umbrella Rank: 25413
gs-cdn.optimonk.com — Cisco Umbrella Rank: 31599
jfapiprod.optimonk.com — Cisco Umbrella Rank: 28065
cdn-asset.optimonk.com — Cisco Umbrella Rank: 45384
cdn-renderer.optimonk.com — Cisco Umbrella Rank: 59227
editor-upload-cdn.optimonk.com — Cisco Umbrella Rank: 61416
437 KB
12 googleapis.com
maps.googleapis.com — Cisco Umbrella Rank: 374
fonts.googleapis.com — Cisco Umbrella Rank: 30
233 KB
7 gstatic.com
maps.gstatic.com
fonts.gstatic.com
190 KB
6 feathr.co
cdn.feathr.co — Cisco Umbrella Rank: 20054
polo.feathr.co — Cisco Umbrella Rank: 16141
marco.feathr.co — Cisco Umbrella Rank: 16556
57 KB
3 google-analytics.com
www.google-analytics.com — Cisco Umbrella Rank: 29
21 KB
2 pardot.com
pi.pardot.com — Cisco Umbrella Rank: 5113
4 KB
2 eehw.net
eehw.net — Cisco Umbrella Rank: 998835
24 KB
2 google.com
www.google.com — Cisco Umbrella Rank: 2
2 KB
2 googletagmanager.com
www.googletagmanager.com — Cisco Umbrella Rank: 40
186 KB
1 cloudflare.com
cdnjs.cloudflare.com — Cisco Umbrella Rank: 228
43 KB
1 adsrvr.org
match.adsrvr.org — Cisco Umbrella Rank: 364
149 B
1 google.de
www.google.de — Cisco Umbrella Rank: 6744
408 B
1 doubleclick.net
stats.g.doubleclick.net — Cisco Umbrella Rank: 84
359 B
1 hansonwade.com
hansonwade.com Failed
info.hansonwade.com — Cisco Umbrella Rank: 281754
1018 B
89 15
Domain Requested by
24 tumor-myeloid-therapeutics.com tumor-myeloid-therapeutics.com
11 maps.googleapis.com www.google.com
maps.googleapis.com
tumor-myeloid-therapeutics.com
8 front.optimonk.com tumor-myeloid-therapeutics.com
front.optimonk.com
5 fonts.gstatic.com fonts.googleapis.com
4 polo.feathr.co cdn.feathr.co
3 editor-upload-cdn.optimonk.com tumor-myeloid-therapeutics.com
3 cdn-asset.optimonk.com front.optimonk.com
3 www.google-analytics.com www.googletagmanager.com
www.google-analytics.com
2 pi.pardot.com tumor-myeloid-therapeutics.com
pi.pardot.com
2 jfapiprod.optimonk.com gs-cdn.optimonk.com
2 maps.gstatic.com www.google.com
tumor-myeloid-therapeutics.com
2 eehw.net tumor-myeloid-therapeutics.com
2 www.google.com tumor-myeloid-therapeutics.com
2 www.googletagmanager.com tumor-myeloid-therapeutics.com
www.googletagmanager.com
1 fonts.googleapis.com front.optimonk.com
1 info.hansonwade.com pi.pardot.com
1 cdnjs.cloudflare.com cdn-asset.optimonk.com
1 match.adsrvr.org tumor-myeloid-therapeutics.com
1 cdn-renderer.optimonk.com front.optimonk.com
1 www.google.de tumor-myeloid-therapeutics.com
1 stats.g.doubleclick.net www.google-analytics.com
1 marco.feathr.co tumor-myeloid-therapeutics.com
1 gs-cdn.optimonk.com tumor-myeloid-therapeutics.com
1 cdn.feathr.co tumor-myeloid-therapeutics.com
1 cdn-account.optimonk.com tumor-myeloid-therapeutics.com
1 onsite.optimonk.com tumor-myeloid-therapeutics.com
0 hansonwade.com Failed tumor-myeloid-therapeutics.com
89 27

This site contains links to these domains. Also see Links.

Domain
eehw.net
register.hansonwade.com
hansonwade.com
hansonwadegroup.com
www.eventengine.tv
Subject Issuer Validity Valid
www.b-cell-directed-therapiescom.eehw.net
R3
2024-02-01 -
2024-05-01
3 months crt.sh
onsite.optimonk.com
R3
2024-03-09 -
2024-06-07
3 months crt.sh
*.google-analytics.com
GTS CA 1C3
2024-02-19 -
2024-05-13
3 months crt.sh
www.google.com
GTS CA 1C3
2024-02-19 -
2024-05-13
3 months crt.sh
inflammasome-therapeutics.com
R3
2024-03-13 -
2024-06-11
3 months crt.sh
cdn-account.optimonk.com
R3
2024-03-09 -
2024-06-07
3 months crt.sh
feathr.co
GTS CA 1P5
2024-02-07 -
2024-05-07
3 months crt.sh
*.optimonk.com
AlphaSSL CA - SHA256 - G4
2023-06-12 -
2024-07-13
a year crt.sh
gs-cdn.optimonk.com
R3
2024-02-25 -
2024-05-25
3 months crt.sh
marco.feathr.co
Amazon RSA 2048 M01
2023-07-23 -
2024-08-20
a year crt.sh
*.gstatic.com
GTS CA 1C3
2024-02-19 -
2024-05-13
3 months crt.sh
upload.video.google.com
GTS CA 1C3
2024-02-19 -
2024-05-13
3 months crt.sh
*.g.doubleclick.net
GTS CA 1C3
2024-02-19 -
2024-05-13
3 months crt.sh
www.google.de
GTS CA 1C3
2024-02-19 -
2024-05-13
3 months crt.sh
jfapiprod.optimonk.com
GTS CA 1D4
2024-03-07 -
2024-06-05
3 months crt.sh
cdn-asset.optimonk.com
R3
2024-02-25 -
2024-05-25
3 months crt.sh
cdn-renderer.optimonk.com
R3
2024-03-01 -
2024-05-30
3 months crt.sh
*.adsrvr.org
GlobalSign GCC R3 DV TLS CA 2020
2023-04-12 -
2024-05-13
a year crt.sh
editor-upload-cdn.optimonk.com
R3
2024-02-25 -
2024-05-25
3 months crt.sh
sni.cloudflaressl.com
Cloudflare Inc ECC CA-3
2023-07-03 -
2024-07-02
a year crt.sh
pi.pardot.com
DigiCert TLS RSA SHA256 2020 CA1
2023-07-25 -
2024-07-23
a year crt.sh
info.hansonwade.com
R3
2024-02-21 -
2024-05-21
3 months crt.sh

This page contains 3 frames:

Primary Page: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Frame ID: 801D407E09F10BD7CF80A3356EF24EE9
Requests: 74 HTTP requests in this frame

Frame: https://www.google.com/maps/embed/v1/place?q=Hilton+Boston+Back+Bay%0A%0A40+Dalton+Street%2C+Boston%2C+MA+02115%2C+United+States&key=AIzaSyD09zQ9PNDNNy9TadMuzRV_UsPUoWKntt8
Frame ID: A1A7DA3F461495E4BA9B71FC646F8D90
Requests: 14 HTTP requests in this frame

Frame: https://cdn-renderer.optimonk.com/ssr/197068/65c392f4a9988b00245fd55d.html?v=1707385710
Frame ID: 7964442E0959F76FEA8A36EED55473ED
Requests: 1 HTTP requests in this frame

Screenshot

Page Title

4th Tumor Myeloid-Directed Therapies Summit 2024 | Register

Detected technologies

Overall confidence: 100%
Detected patterns
  • <link rel=["']stylesheet["'] [^>]+/wp-(?:content|includes)/
  • /wp-(?:content|includes)/

Overall confidence: 100%
Detected patterns
  • //maps\.google(?:apis)?\.com/maps/api/js

Overall confidence: 100%
Detected patterns
  • <!-- This site is optimized with the Yoast (?:WordPress )?SEO plugin v([\d.]+) -

Overall confidence: 100%
Detected patterns
  • <link[^>]* href=[^>]*?(?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)
  • (?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:.*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)

Overall confidence: 100%
Detected patterns
  • google-analytics\.com/(?:ga|urchin|analytics)\.js

Overall confidence: 100%
Detected patterns
  • googletagmanager\.com/gtm\.js
  • googletagmanager\.com/gtag/js

Overall confidence: 100%
Detected patterns
  • jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

Overall confidence: 100%
Detected patterns
  • jquery[.-]migrate(?:-([\d.]+))?(?:\.min)?\.js(?:\?ver=([\d.]+))?

Page Statistics

89
Requests

96 %
HTTPS

68 %
IPv6

15
Domains

27
Subdomains

23
IPs

4
Countries

1705 kB
Transfer

4398 kB
Size

18
Cookies

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 15
  • https://info.hansonwade.com/createCookieForUtmParam HTTP 0
  • http://hansonwade.com/
Request Chain 16
  • https://info.hansonwade.com/dynamicIframeHeightListener HTTP 0
  • http://hansonwade.com/

89 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request /
tumor-myeloid-therapeutics.com/take-part/register/
244 KB
47 KB
Document
General
Full URL
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
1fc3ceaef1ecbef2185adc7b00ff019567c34e9e3129609761b770a91b077ad4
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36
accept-language
en-GB,en;q=0.9

Response headers

access-control-allow-origin
*
alt-svc
h3=":443"; ma=2592000, h3-29=":443"; ma=2592000, h3-Q050=":443"; ma=2592000, h3-Q046=":443"; ma=2592000, h3-Q043=":443"; ma=2592000, quic=":443"; ma=2592000; v="43,46"
content-encoding
br
content-length
46493
content-type
text/html; charset=UTF-8
date
Thu, 14 Mar 2024 10:03:19 GMT
edit
Set-Cookie ^(.*)$ $1;Secure
etag
"3066378-1710365865;br"
link
<https://tumor-myeloid-therapeutics.com/wp-json/>; rel="https://api.w.org/" <https://tumor-myeloid-therapeutics.com/wp-json/wp/v2/pages/150>; rel="alternate"; type="application/json" <https://tumor-myeloid-therapeutics.com/?p=150>; rel=shortlink
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
referrer-policy
no-referrer-when-downgrade
server
LiteSpeed
strict-transport-security
max-age=31536000
vary
Accept-Encoding,User-Agent
x-content-type-options
nosniff
x-frame-options
SAMEORIGIN
x-litespeed-cache
hit
x-xss-protection
1; mode=block
fa-solid-900.woff2
tumor-myeloid-therapeutics.com/wp-content/plugins/bb-plugin/fonts/fontawesome/5.15.4/webfonts/
76 KB
77 KB
Font
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-content/plugins/bb-plugin/fonts/fontawesome/5.15.4/webfonts/fa-solid-900.woff2
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
9834b82ad26e2a37583d22676a12dd2eb0fe7c80356a2114d0db1aa8b3899537
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Origin
https://tumor-myeloid-therapeutics.com
accept-language
en-GB,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:19 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
referrer-policy
no-referrer-when-downgrade
last-modified
Wed, 13 Mar 2024 21:33:21 GMT
server
LiteSpeed
vary
User-Agent
x-frame-options
SAMEORIGIN
content-type
font/woff2
access-control-allow-origin
*
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
content-length
78268
x-xss-protection
1; mode=block
edit
Set-Cookie ^(.*)$ $1;Secure
fa-regular-400.woff2
tumor-myeloid-therapeutics.com/wp-content/plugins/bb-plugin/fonts/fontawesome/5.15.4/webfonts/
13 KB
13 KB
Font
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-content/plugins/bb-plugin/fonts/fontawesome/5.15.4/webfonts/fa-regular-400.woff2
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
e42a88444448ac3d60549cc7c1ff2c8a9cac721034c073d80a14a44e79730cca
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Origin
https://tumor-myeloid-therapeutics.com
accept-language
en-GB,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:19 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
referrer-policy
no-referrer-when-downgrade
last-modified
Wed, 13 Mar 2024 21:33:21 GMT
server
LiteSpeed
vary
User-Agent
x-frame-options
SAMEORIGIN
content-type
font/woff2
access-control-allow-origin
*
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
content-length
13224
x-xss-protection
1; mode=block
edit
Set-Cookie ^(.*)$ $1;Secure
style.min.css
tumor-myeloid-therapeutics.com/wp-includes/css/dist/block-library/
108 KB
13 KB
Stylesheet
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-includes/css/dist/block-library/style.min.css?ver=6.4.3
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
0085adfd2d08a45f62a06d8f3f969ddc4a94ebe8d226511db90aa038f11ed180
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:19 GMT
date
Thu, 14 Mar 2024 10:03:19 GMT
content-encoding
br
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
content-length
13600
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Thu, 01 Feb 2024 21:18:54 GMT
server
LiteSpeed
vary
Accept-Encoding,User-Agent
x-frame-options
SAMEORIGIN
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
all.min.css
tumor-myeloid-therapeutics.com/wp-content/plugins/bb-plugin/fonts/fontawesome/5.15.4/css/
58 KB
12 KB
Stylesheet
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-content/plugins/bb-plugin/fonts/fontawesome/5.15.4/css/all.min.css?ver=2.8.0.4
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
99464ceb71bc9bbdcc72275faefe44f98eb5cbb6b5d8ee665b87b35376f1a96e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:19 GMT
date
Thu, 14 Mar 2024 10:03:19 GMT
content-encoding
br
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
content-length
12370
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Wed, 13 Mar 2024 21:33:21 GMT
server
LiteSpeed
vary
Accept-Encoding,User-Agent
x-frame-options
SAMEORIGIN
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
custom-styles.css
tumor-myeloid-therapeutics.com/wp-content/plugins/ee-hw-addons/
8 KB
2 KB
Stylesheet
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-content/plugins/ee-hw-addons/custom-styles.css?ver=6.4.3
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
6f8434dddddec77ec8185a56d50b89a96f9b99bc1a12f44913ee8db023c7b142
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:19 GMT
date
Thu, 14 Mar 2024 10:03:19 GMT
content-encoding
br
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
content-length
1622
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Fri, 01 Sep 2023 05:04:15 GMT
server
LiteSpeed
vary
Accept-Encoding,User-Agent
x-frame-options
SAMEORIGIN
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
style.css
tumor-myeloid-therapeutics.com/wp-content/plugins/ee-network-plugin/css/
2 KB
603 B
Stylesheet
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-content/plugins/ee-network-plugin/css/style.css?ver=20120208
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
fd8c99c4cb3d00be1c4f9954a0e346381f683691c3f4def26e099b5e7573826a
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:19 GMT
date
Thu, 14 Mar 2024 10:03:19 GMT
content-encoding
br
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
content-length
539
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Mon, 17 Feb 2020 10:31:39 GMT
server
LiteSpeed
vary
Accept-Encoding,User-Agent
x-frame-options
SAMEORIGIN
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
pagenavi-css.css
tumor-myeloid-therapeutics.com/wp-content/plugins/wp-pagenavi/
374 B
247 B
Stylesheet
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-content/plugins/wp-pagenavi/pagenavi-css.css?ver=2.70
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
c2711e9edc60964dcb5aada1bfa59c2d68d3d9dc1baf4a5ee058b4c1bd32c3eb
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:19 GMT
date
Thu, 14 Mar 2024 10:03:19 GMT
content-encoding
br
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
content-length
183
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Thu, 11 May 2023 20:52:39 GMT
server
LiteSpeed
vary
Accept-Encoding,User-Agent
x-frame-options
SAMEORIGIN
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
front.min.css
tumor-myeloid-therapeutics.com/wp-content/plugins/cookie-notice/css/
5 KB
1015 B
Stylesheet
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-content/plugins/cookie-notice/css/front.min.css?ver=2.4.15
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
029dedf319bc4536d9c663ae9c0b10c95d1e9f5dd1de0aa73172e9e89ae254cc
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:19 GMT
date
Thu, 14 Mar 2024 10:03:19 GMT
content-encoding
br
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
content-length
951
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Wed, 06 Mar 2024 22:49:09 GMT
server
LiteSpeed
vary
Accept-Encoding,User-Agent
x-frame-options
SAMEORIGIN
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
v4-shims.min.css
tumor-myeloid-therapeutics.com/wp-content/plugins/bb-plugin/fonts/fontawesome/5.15.4/css/
26 KB
4 KB
Stylesheet
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-content/plugins/bb-plugin/fonts/fontawesome/5.15.4/css/v4-shims.min.css?ver=2.8.0.4
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
8fe2f1cb7bc41c640ad3ea24449cfa1ba5291e16dbbbab0ef61bfe43f3212910
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:19 GMT
date
Thu, 14 Mar 2024 10:03:19 GMT
content-encoding
br
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
content-length
3987
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Wed, 13 Mar 2024 21:33:21 GMT
server
LiteSpeed
vary
Accept-Encoding,User-Agent
x-frame-options
SAMEORIGIN
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
jquery.magnificpopup.min.css
tumor-myeloid-therapeutics.com/wp-content/plugins/bb-plugin/css/
6 KB
1 KB
Stylesheet
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-content/plugins/bb-plugin/css/jquery.magnificpopup.min.css?ver=2.8.0.4
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
b698d7d63c8c236cda0499131978654fa884f24df6755f7b6909e5d784e096db
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:19 GMT
date
Thu, 14 Mar 2024 10:03:19 GMT
content-encoding
br
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
content-length
1463
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Wed, 13 Mar 2024 21:33:21 GMT
server
LiteSpeed
vary
Accept-Encoding,User-Agent
x-frame-options
SAMEORIGIN
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
base.min.css
tumor-myeloid-therapeutics.com/wp-content/themes/bb-theme/css/
47 KB
8 KB
Stylesheet
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-content/themes/bb-theme/css/base.min.css?ver=1.7.15.2
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
1e8dcaec98f99c2b1b43ff8b8655680b69bbf150470b20ecbdd1cb45570a0587
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:19 GMT
date
Thu, 14 Mar 2024 10:03:19 GMT
content-encoding
br
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
content-length
8400
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Wed, 13 Mar 2024 21:34:15 GMT
server
LiteSpeed
vary
Accept-Encoding,User-Agent
x-frame-options
SAMEORIGIN
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
style.css
tumor-myeloid-therapeutics.com/wp-content/themes/ee-six-builder-child/
2 KB
787 B
Stylesheet
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-content/themes/ee-six-builder-child/style.css?ver=6.4.3
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
8a0cfc6d0e8d7d52cd98a428a467a1e603e108c041b50dc2e50d77435ad9e721
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:19 GMT
date
Thu, 14 Mar 2024 10:03:19 GMT
content-encoding
br
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
content-length
723
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Tue, 12 Sep 2023 15:41:30 GMT
server
LiteSpeed
vary
Accept-Encoding,User-Agent
x-frame-options
SAMEORIGIN
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
jquery.min.js
tumor-myeloid-therapeutics.com/wp-includes/js/jquery/
86 KB
29 KB
Script
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-includes/js/jquery/jquery.min.js?ver=3.7.1
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
cb6f2d32c49d1c2b25e9ffc9aaafa3f83075346c01bcd4ae6eb187392a4292cf
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:19 GMT
date
Thu, 14 Mar 2024 10:03:19 GMT
content-encoding
br
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
content-length
29744
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Wed, 29 Nov 2023 21:12:39 GMT
server
LiteSpeed
vary
Accept-Encoding,User-Agent
x-frame-options
SAMEORIGIN
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
jquery-migrate.min.js
tumor-myeloid-therapeutics.com/wp-includes/js/jquery/
13 KB
5 KB
Script
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=3.4.1
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
5274f11e6fb32ae0cf2dfb9f8043272865c397a7c4223b4cfa7d50ea52fbde89
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:19 GMT
date
Thu, 14 Mar 2024 10:03:19 GMT
content-encoding
br
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
content-length
4678
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Wed, 06 Sep 2023 20:23:05 GMT
server
LiteSpeed
vary
Accept-Encoding,User-Agent
x-frame-options
SAMEORIGIN
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
front.min.js
tumor-myeloid-therapeutics.com/wp-content/plugins/cookie-notice/js/
8 KB
3 KB
Script
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-content/plugins/cookie-notice/js/front.min.js?ver=2.4.15
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
08756c47213d461baa3b01f42448a76d11f524470c7a34f9018733889bd4f49c
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:19 GMT
date
Thu, 14 Mar 2024 10:03:19 GMT
content-encoding
br
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
alt-svc
h3=":443"; ma=2592000, h3-29=":443"; ma=2592000, h3-Q050=":443"; ma=2592000, h3-Q046=":443"; ma=2592000, h3-Q043=":443"; ma=2592000, quic=":443"; ma=2592000; v="43,46"
content-length
1964
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Wed, 06 Mar 2024 22:49:09 GMT
server
LiteSpeed
vary
Accept-Encoding,User-Agent
x-frame-options
SAMEORIGIN
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
/
hansonwade.com/
Redirect Chain
  • https://info.hansonwade.com/createCookieForUtmParam
  • http://hansonwade.com/
0
0

/
hansonwade.com/
Redirect Chain
  • https://info.hansonwade.com/dynamicIframeHeightListener
  • http://hansonwade.com/
0
0

5fbbf4a5-9b65-49b5-ad43-feec44f21193
https://tumor-myeloid-therapeutics.com/
1 KB
0
Other
General
Full URL
blob:https://tumor-myeloid-therapeutics.com/5fbbf4a5-9b65-49b5-ad43-feec44f21193
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
BLOB
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
453cb806084fdabec32e286af2e88899f79022125c2527afffbec507975d2c22

Request headers

accept-language
en-GB,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

Content-Length
1245
Content-Type
text/javascript
jquery.imagesloaded.min.js
tumor-myeloid-therapeutics.com/wp-content/plugins/bb-plugin/js/
5 KB
2 KB
Script
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-content/plugins/bb-plugin/js/jquery.imagesloaded.min.js?ver=2.8.0.4
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
bc6141baf0bde0e41c12e9311f5a97c158a7cb99f923afeb67d13abeaacb652b
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:19 GMT
date
Thu, 14 Mar 2024 10:03:19 GMT
content-encoding
br
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
content-length
1714
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Wed, 13 Mar 2024 21:33:21 GMT
server
LiteSpeed
vary
Accept-Encoding,User-Agent
x-frame-options
SAMEORIGIN
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
jquery.ba-throttle-debounce.min.js
tumor-myeloid-therapeutics.com/wp-content/plugins/bb-plugin/js/
731 B
449 B
Script
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-content/plugins/bb-plugin/js/jquery.ba-throttle-debounce.min.js?ver=2.8.0.4
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
fa7b84bb6e37fba06f79793937e55baf6ebc1bee051e350e11c7ca681a9f3db7
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:19 GMT
date
Thu, 14 Mar 2024 10:03:19 GMT
content-encoding
br
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
content-length
408
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Wed, 13 Mar 2024 21:33:21 GMT
server
LiteSpeed
vary
Accept-Encoding,User-Agent
x-frame-options
SAMEORIGIN
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
jquery.magnificpopup.min.js
tumor-myeloid-therapeutics.com/wp-content/plugins/bb-plugin/js/
20 KB
7 KB
Script
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-content/plugins/bb-plugin/js/jquery.magnificpopup.min.js?ver=2.8.0.4
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
41be528bffc12cc0c4ff46c1227e0f2165752c63787b7735276053c741082563
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:19 GMT
date
Thu, 14 Mar 2024 10:03:19 GMT
content-encoding
br
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
content-length
6904
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Wed, 13 Mar 2024 21:33:21 GMT
server
LiteSpeed
vary
Accept-Encoding,User-Agent
x-frame-options
SAMEORIGIN
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
theme.min.js
tumor-myeloid-therapeutics.com/wp-content/themes/bb-theme/js/
23 KB
5 KB
Script
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-content/themes/bb-theme/js/theme.min.js?ver=1.7.15.2
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
3e01664f9d65a47fa97a4485a9fb73ae53f05ac5b5eb4e26d162e400a861e496
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:19 GMT
date
Thu, 14 Mar 2024 10:03:19 GMT
content-encoding
br
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
content-length
5331
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Wed, 13 Mar 2024 21:34:15 GMT
server
LiteSpeed
vary
Accept-Encoding,User-Agent
x-frame-options
SAMEORIGIN
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
script.js
onsite.optimonk.com/
174 KB
55 KB
Script
General
Full URL
https://onsite.optimonk.com/script.js?account=197068
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2400:52e0:1e00::1082:1 , Germany, ASN200325 (BUNNYCDN, SI),
Reverse DNS
Software
BunnyCDN-DE1-1082 /
Resource Hash
cfcb39754317eebb2461f23777ca13575defecfbe48092ebde5fdb08e50a9631
Security Headers
Name Value
Strict-Transport-Security max-age=15552000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:20 GMT
strict-transport-security
max-age=15552000; includeSubDomains
x-content-type-options
nosniff
content-encoding
br
cdn-edgestorageid
1080
x-dns-prefetch-control
off
cdn-cachedat
03/14/2024 08:57:04
cdn-pullzone
950289
x-xss-protection
1; mode=block
server
BunnyCDN-DE1-1082
cdn-proxyver
1.04
cdn-requestpullcode
200
etag
W/"2b8e8-Q5ZopNYv6zWe57v7CJf7eXppZEc"
x-download-options
noopen
vary
Accept-Encoding, Accept-Encoding
x-frame-options
SAMEORIGIN
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cdn-cache
HIT
cdn-uid
03887a3a-e2eb-4f9c-b547-bb29001e27f6
cache-control
public, max-age=180
cdn-requestid
2675d4cbb48778aae54adec583b35f65
cdn-requestcountrycode
DE
cdn-status
200
cdn-requestpullsuccess
True
gtm.js
www.googletagmanager.com/
261 KB
91 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-M2F29MK
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80e::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
e3092c7037bec2117a6ca8d98679f49ff8c67919db23e581bd5e2d32a423cec4
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:20 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
93162
x-xss-protection
0
last-modified
Thu, 14 Mar 2024 09:00:00 GMT
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Thu, 14 Mar 2024 10:03:20 GMT
place
www.google.com/maps/embed/v1/ Frame A1A7
3 KB
2 KB
Document
General
Full URL
https://www.google.com/maps/embed/v1/place?q=Hilton+Boston+Back+Bay%0A%0A40+Dalton+Street%2C+Boston%2C+MA+02115%2C+United+States&key=AIzaSyD09zQ9PNDNNy9TadMuzRV_UsPUoWKntt8
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
scaffolding on HTTPServer2 /
Resource Hash
b2f915134890f1ac17359b02564def9a114f041939968e3a6ee7df51c82dca0c
Security Headers
Name Value
Content-Security-Policy object-src 'none';base-uri 'self';script-src 'nonce-kmpobagCdDTPOjn31p9Fmw' 'strict-dynamic' 'report-sample' 'unsafe-eval' 'unsafe-inline' https: http:;report-uri https://csp.withgoogle.com/csp/geo-maps-api/1
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36
accept-language
en-GB,en;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, must-revalidate
content-encoding
gzip
content-length
1323
content-security-policy
object-src 'none';base-uri 'self';script-src 'nonce-kmpobagCdDTPOjn31p9Fmw' 'strict-dynamic' 'report-sample' 'unsafe-eval' 'unsafe-inline' https: http:;report-uri https://csp.withgoogle.com/csp/geo-maps-api/1
content-type
text/html; charset=UTF-8
date
Thu, 14 Mar 2024 10:03:20 GMT
expires
Fri, 01 Jan 1990 00:00:00 GMT
pragma
no-cache
server
scaffolding on HTTPServer2
vary
Accept-Language Origin X-Origin Referer
x-content-type-options
nosniff
x-xss-protection
0
Background-scaled.jpg
tumor-myeloid-therapeutics.com/wp-content/uploads/sites/329/2023/03/
225 KB
225 KB
Image
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-content/uploads/sites/329/2023/03/Background-scaled.jpg
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
8c26ac81933e67b0ca97878bba29f2bccc68dccd8edfec641fe727c3fe15061e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:19 GMT
date
Thu, 14 Mar 2024 10:03:19 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
content-length
230111
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Thu, 16 Mar 2023 08:59:29 GMT
server
LiteSpeed
vary
User-Agent
x-frame-options
SAMEORIGIN
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
search.png
tumor-myeloid-therapeutics.com/wp-content/plugins/ee-hw-addons/ee-search/includes/img/
1 KB
1 KB
Image
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-content/plugins/ee-hw-addons/ee-search/includes/img/search.png
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
b7e6b0faec1066164436858dbc2fd7f23cd9d99c5eeae77c84701a1a6a7cc120
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:19 GMT
date
Thu, 14 Mar 2024 10:03:19 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
content-length
1341
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Fri, 18 Nov 2022 13:05:20 GMT
server
LiteSpeed
vary
User-Agent
x-frame-options
SAMEORIGIN
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
6b0e5876-b940-11ee-98d2-525400cb626e.png
tumor-myeloid-therapeutics.com/wp-content/uploads/sites/329/2018/09/
44 KB
44 KB
Image
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-content/uploads/sites/329/2018/09/6b0e5876-b940-11ee-98d2-525400cb626e.png
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
9810928f8999fcf00c32500bd85711c81a7466f1a1ba1e5f7912a3dc2db3ddc7
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:19 GMT
date
Thu, 14 Mar 2024 10:03:19 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
content-length
45437
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Tue, 23 Jan 2024 19:57:08 GMT
server
LiteSpeed
vary
User-Agent
x-frame-options
SAMEORIGIN
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
white-logo.png
eehw.net/images/
6 KB
7 KB
Image
General
Full URL
https://eehw.net/images/white-logo.png
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
ea5b4ba7ea650f85605fbdc26de0863588b3c65a2a422c799800a5d3185df558
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:20 GMT
date
Thu, 14 Mar 2024 10:03:20 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
alt-svc
h3=":443"; ma=2592000, h3-29=":443"; ma=2592000, h3-Q050=":443"; ma=2592000, h3-Q046=":443"; ma=2592000, h3-Q043=":443"; ma=2592000, quic=":443"; ma=2592000; v="43,46"
content-length
6455
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Mon, 22 Jan 2024 14:37:50 GMT
server
LiteSpeed
vary
User-Agent
x-frame-options
SAMEORIGIN
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
HWG-1-1.png
eehw.net/images/
17 KB
17 KB
Image
General
Full URL
https://eehw.net/images/HWG-1-1.png
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
c26d54c0def8b5349639f5e5b09b469657ec9ce8ef9f57ecc8d33c5ae960daa3
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:20 GMT
date
Thu, 14 Mar 2024 10:03:20 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
alt-svc
h3=":443"; ma=2592000, h3-29=":443"; ma=2592000, h3-Q050=":443"; ma=2592000, h3-Q046=":443"; ma=2592000, h3-Q043=":443"; ma=2592000, quic=":443"; ma=2592000; v="43,46"
content-length
17460
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Mon, 22 Jan 2024 14:38:08 GMT
server
LiteSpeed
vary
User-Agent
x-frame-options
SAMEORIGIN
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
wp-emoji-release.min.js
tumor-myeloid-therapeutics.com/wp-includes/js/
18 KB
5 KB
Script
General
Full URL
https://tumor-myeloid-therapeutics.com/wp-includes/js/wp-emoji-release.min.js?ver=6.4.3
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
5.134.13.35 , United Kingdom, ASN34282 (UKNOC-AS, GB),
Reverse DNS
eehw.gds.guru.net.uk
Software
LiteSpeed /
Resource Hash
4f79a89d16a5f717110fe080c0bf90b7e05ff95a4c4983f64d33110bf5f9c230
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

expires
Thu, 21 Mar 2024 10:03:19 GMT
date
Thu, 14 Mar 2024 10:03:19 GMT
content-encoding
br
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
content-length
4651
x-xss-protection
1; mode=block
referrer-policy
no-referrer-when-downgrade
last-modified
Thu, 13 Apr 2023 20:37:21 GMT
server
LiteSpeed
vary
Accept-Encoding,User-Agent
x-frame-options
SAMEORIGIN
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=604800
permissions-policy
accelerometer=(self), ambient-light-sensor=(self), autoplay=(self), battery=(self), camera=(self), cross-origin-isolated=(self), display-capture=(self), document-domain=(self), encrypted-media=(self), execution-while-not-rendered=(self), execution-while-out-of-viewport=(self), fullscreen=(self), geolocation=(self), gyroscope=(self), keyboard-map=(self), magnetometer=(self), microphone=(self), midi=(self), navigation-override=(self), payment=(self), picture-in-picture=(self), publickey-credentials-get=(self), screen-wake-lock=(self), sync-xhr=(self), usb=(self), web-share=(self), xr-spatial-tracking=(self)
accept-ranges
bytes
edit
Set-Cookie ^(.*)$ $1;Secure
accountInfo.json
cdn-account.optimonk.com/197068/
186 B
946 B
XHR
General
Full URL
https://cdn-account.optimonk.com/197068/accountInfo.json
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2400:52e0:1e00::1080:1 , Germany, ASN200325 (BUNNYCDN, SI),
Reverse DNS
Software
BunnyCDN-DE1-1080 /
Resource Hash
9d2447ea244da8cd9d660a6e5c1eaab7beca6c7ae3e31f22ddc94d4c6b2b4fd6
Security Headers
Name Value
Strict-Transport-Security max-age=15552000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:20 GMT
strict-transport-security
max-age=15552000; includeSubDomains
x-content-type-options
nosniff
content-encoding
br
cdn-edgestorageid
1081
x-dns-prefetch-control
off
cdn-cachedat
03/14/2024 09:37:55
cdn-pullzone
951434
x-xss-protection
1; mode=block
server
BunnyCDN-DE1-1080
cdn-proxyver
1.04
x-bunnycdn-countrycode
DE
etag
W/"ba-CMIsCofPky2Kl7zRpi16/ZWABWQ"
x-download-options
noopen
vary
Accept-Encoding
x-frame-options
SAMEORIGIN
content-type
application/json; charset=utf-8
access-control-allow-origin
*
cdn-cache
HIT
cdn-uid
03887a3a-e2eb-4f9c-b547-bb29001e27f6
access-control-expose-headers
X-BunnyCDN-CountryCode
cache-control
public, max-age=30
cdn-requestpullcode
200
cdn-requestid
125beaf88b8eb12a6a2c3b0ef3d404d5
cdn-requestcountrycode
DE
access-control-allow-headers
Server, x-goog-meta-frames, Content-Length, Content-Type, Range, X-Requested-With, If-Modified-Since, If-None-Match
cdn-status
200
cdn-requestpullsuccess
True
js
www.googletagmanager.com/gtag/
283 KB
94 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=G-ED2F8XSC1V&l=dataLayer&cx=c
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-M2F29MK
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80e::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
fdb358a49f9084489b4c36c9fb8ea0a4649d8b07041095b9239c813768284802
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:20 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
access-control-allow-headers
Cache-Control
content-length
96650
x-xss-protection
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Thu, 14 Mar 2024 10:03:20 GMT
analytics.js
www.google-analytics.com/
52 KB
21 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-M2F29MK
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
de36e50194320a7d3ef1ace9bd34a875a8bd458b253c061979dd628e9bf49afd
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
date
Thu, 14 Mar 2024 09:48:08 GMT
last-modified
Tue, 12 Dec 2023 18:09:08 GMT
server
Golfe2
age
912
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
20994
expires
Thu, 14 Mar 2024 11:48:08 GMT
boomerang.min.js
cdn.feathr.co/js/
190 KB
54 KB
Script
General
Full URL
https://cdn.feathr.co/js/boomerang.min.js
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::681a:f77 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
96924bdccaf2ca3b83e7c118d860c894502362f283892c3e82e0a286d6af48ad

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:20 GMT
x-amz-version-id
NqRC8_Plav5AfcaAdW08YJ.wtJTZFgWZ
content-encoding
br
cf-cache-status
HIT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
x-amz-request-id
A7DNEFGKYFJP74Z3
age
4781
x-amz-id-2
LdETC1FjUHNuEKKb0NPgyY3YJV+kOZwOBq4CdydINrrj7z6DqgVlMDJjYp713lEI9ndCA7yoIDU=
last-modified
Thu, 30 Nov 2023 16:52:54 GMT
server
cloudflare
etag
W/"0ff7cc26823f4b5ff7b6386036a3101a"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=oJ%2FoqgHmz%2BYwa0o8RUzZZTSoT95fpJJKFbF3kOC8yP0GjISu8l1Y%2Bt6bcNWbwhG9JxsR%2BaDlshR%2Fz%2BxeI%2FRDA33sUqLhUJ%2FiP84hRF1hwTfqIGKxvjHZ4NcGs75Ll6Xr%2FnjlASDyQXC15uk%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/javascript; charset=utf-8
cache-control
max-age=14400
cf-ray
86436eec0cb77711-LHR
collect
www.google-analytics.com/g/
0
181 B
Ping
General
Full URL
https://www.google-analytics.com/g/collect?v=2&tid=G-ED2F8XSC1V&gtm=45je43b0v9176013485z8832982191za200&_p=1710410599852&gcd=13l3l3l3l1&npa=0&dma=0&cid=1821384544.1710410600&ul=en-us&sr=1600x1200&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&pscdl=noapi&_s=1&sid=1710410600&sct=1&seg=0&dl=https%3A%2F%2Ftumor-myeloid-therapeutics.com%2Ftake-part%2Fregister%2F%3Futm_source%3Dexternal%26utm_medium%3Demail%26utm_campaign%3Dlaunch%26utm_content%3Dmedia-partner%2Fpharma-journalist%2Fpaid%2Fmarch%2Fem-01%2Fev-47521&dt=4th%20Tumor%20Myeloid-Directed%20Therapies%20Summit%202024%20%7C%20Register&en=page_view&_fv=1&_nsi=1&_ss=1&tfd=1121
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-ED2F8XSC1V&l=dataLayer&cx=c
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 14 Mar 2024 10:03:20 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://tumor-myeloid-therapeutics.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
after-pre-init
front.optimonk.com/public/197068/embedded/
152 B
508 B
XHR
General
Full URL
https://front.optimonk.com/public/197068/embedded/after-pre-init
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
188.166.193.169 Frankfurt am Main, Germany, ASN14061 (DIGITALOCEAN-ASN, US),
Reverse DNS
Software
nginx /
Resource Hash
7647a4c48c5804e526f18b451327c1496cfbb04e6c01b806e7e8991cd60c3c42
Security Headers
Name Value
Strict-Transport-Security max-age=15552000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
accept-language
en-GB,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36
Content-type
application/x-www-form-urlencoded

Response headers

date
Thu, 14 Mar 2024 10:03:20 GMT
strict-transport-security
max-age=15552000; includeSubDomains
x-content-type-options
nosniff
content-encoding
gzip
server
nginx
etag
W/"98-lC3A9CNC58A3Xk5qtOzmLLQkxH0"
x-download-options
noopen
x-frame-options
SAMEORIGIN
vary
Accept-Encoding, Accept-Encoding
content-type
text/html; charset=utf-8
x-dns-prefetch-control
off
access-control-allow-origin
*
cache-control
no-cache
x-xss-protection
1; mode=block
jfclientsdk.min.js
gs-cdn.optimonk.com/jfclientsdk/latest/
90 KB
31 KB
Script
General
Full URL
https://gs-cdn.optimonk.com/jfclientsdk/latest/jfclientsdk.min.js?ts=14
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2400:52e0:1e00::1081:1 , Germany, ASN200325 (BUNNYCDN, SI),
Reverse DNS
Software
BunnyCDN-DE1-1081 /
Resource Hash
9010a9a09595aa5d0b6a09b1919f92093dd5e35409765278187242239fb6b262

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:20 GMT
content-encoding
br
cdn-edgestorageid
1081
age
12
x-guploader-uploadid
ABPtcPqRPhCaanEJPlXCEWu2FIewHqeSj2qIz6D18a58QMlcbdKtXxt1NsDdkCF7K9Im-wQYHEo
x-goog-storage-class
STANDARD
x-goog-metageneration
1
cdn-cachedat
03/11/2024 14:53:43
cdn-pullzone
592317
x-goog-stored-content-encoding
identity
alt-svc
h3=":443"; ma=2592000, h3-29=":443"; ma=2592000
last-modified
Mon, 11 Mar 2024 14:53:27 GMT
server
BunnyCDN-DE1-1081
cdn-proxyver
1.04
cdn-requestpullcode
200
etag
W/"0f046f1c616db2c75c062e202e1b6c9e"
vary
Accept-Encoding, Accept-Encoding
x-goog-generation
1710168807753307
content-type
application/javascript
cdn-cache
HIT
x-goog-hash
crc32c=5t8m6g==, md5=DwRvHGFtssdcBi4gLhtsng==
cdn-uid
03887a3a-e2eb-4f9c-b547-bb29001e27f6
cache-control
public, max-age=2592000
x-goog-stored-content-length
91978
cdn-requestid
56fbfbe3f27ffbaa42ad1627c176397f
cdn-requestcountrycode
DE
cdn-status
200
cdn-requestpullsuccess
True
preload.js
front.optimonk.com/public/197068/js/
5 KB
2 KB
Script
General
Full URL
https://front.optimonk.com/public/197068/js/preload.js?
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
188.166.193.169 Frankfurt am Main, Germany, ASN14061 (DIGITALOCEAN-ASN, US),
Reverse DNS
Software
nginx /
Resource Hash
fabdfdbb4b2b7fee11f4ca4a9c796f8d2915c422460f1398c7b726c61ac77e45
Security Headers
Name Value
Strict-Transport-Security max-age=15552000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:20 GMT
strict-transport-security
max-age=15552000; includeSubDomains
x-content-type-options
nosniff
content-encoding
gzip
server
nginx
etag
W/"141b-xPprWpzkQXS1iwUbs5MVgQtfmI0"
x-download-options
noopen
x-dns-prefetch-control
off
x-frame-options
SAMEORIGIN
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public, max-age=1350
vary
Accept-Encoding
x-xss-protection
1; mode=block
collect
www.google-analytics.com/j/
4 B
94 B
XHR
General
Full URL
https://www.google-analytics.com/j/collect?v=1&_v=j101&a=821287313&t=pageview&_s=1&dl=https%3A%2F%2Ftumor-myeloid-therapeutics.com%2Ftake-part%2Fregister%2F%3Futm_source%3Dexternal%26utm_medium%3Demail%26utm_campaign%3Dlaunch%26utm_content%3Dmedia-partner%2Fpharma-journalist%2Fpaid%2Fmarch%2Fem-01%2Fev-47521&ul=en-us&de=UTF-8&dt=4th%20Tumor%20Myeloid-Directed%20Therapies%20Summit%202024%20%7C%20Register&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=YCDACEABBAAAACAAI~&jid=2034608825&gjid=1043686127&cid=1821384544.1710410600&tid=UA-38242463-64&_gid=270194605.1710410600&_r=1&_slc=1&gtm=45He43b0n81M2F29MKv832982191za200&gcd=13l3l3l3l1&dma=0&z=418915669
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
aec60bc104db041b1512185839f18f52986df7e569e5445f740dd60f763fbca8
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
accept-language
en-GB,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Thu, 14 Mar 2024 10:03:20 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://tumor-myeloid-therapeutics.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
4
expires
Fri, 01 Jan 1990 00:00:00 GMT
integrations
polo.feathr.co/v1/accounts/5dfbace0aab76b48e7dec78e/
31 B
694 B
XHR
General
Full URL
https://polo.feathr.co/v1/accounts/5dfbace0aab76b48e7dec78e/integrations
Requested by
Host: cdn.feathr.co
URL: https://cdn.feathr.co/js/boomerang.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::ac43:4415 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
6ab7a652bed5ae700e17ab04683a1e8c9fc3b3794e0c6ee0b564d272aa38739b
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:20 GMT
x-content-type-options
nosniff
cf-cache-status
DYNAMIC
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
access-control-allow-methods
DELETE, GET, OPTIONS, PATCH, POST, PUT
content-type
application/json
access-control-allow-origin
*
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=zyniDITzZElk5xGDaaR7T9ap47HQqQpBmgCQ41AmwZg8t6Ia4hlFa54HpGWV6zf%2BUesfgNyrdITju0Al1Vk66wPqDBJUz1gefJTRqrT%2BPk4inzcHbsKLSU1BApewhMRngbMRbHm8%2BWdPeBHX"}],"group":"cf-nel","max_age":604800}
access-control-allow-credentials
true
cf-ray
86436eed6b7b4888-LHR
access-control-allow-headers
AccountId, Authorization, Cache-Control, Content-Type, DNT, If-Modified-Since, Keep-Alive, Range, ReportObject, ReportType, User-Agent, X-API-Key, X-Requested-With
content-length
31
refresh
marco.feathr.co/v1/
43 B
625 B
Image
General
Full URL
https://marco.feathr.co/v1/refresh
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.66.43 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-65-9-66-43.fra56.r.cloudfront.net
Software
/
Resource Hash
98b3d9d20e032f90aca49e9b116225d539ff6fbdb7e42c3c363f63896ac03d2a

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:20 GMT
via
1.1 5ab5e654a3dc7079aad7ac64ec697d82.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA56-C1
x-amzn-requestid
8a60726e-c876-4cb9-b2fa-4ff9d4f41891
x-amzn-trace-id
Root=1-65f2cb68-47da52f5074e9a0c46b56b2d;Parent=5388d762d8a99112;Sampled=0;lineage=5eb2f403:0
access-control-allow-methods
*
content-type
image/gif
access-control-allow-origin
*
x-cache
Miss from cloudfront
x-amz-apigw-id
UnS4bF93IAMEC1A=
content-length
43
x-amz-cf-id
oHh-0vPPx4OFVz37x8L815jutwFcc7KpmvejnV9247VjeZv9xj7uHQ==
access-control-allow-headers
Content-Type,X-Amz-Date,Authorization,X-Api-Key
init_embed.js
maps.gstatic.com/maps-api-v3/embed/js/56/4/intl/en_gb/ Frame A1A7
228 KB
61 KB
Script
General
Full URL
https://maps.gstatic.com/maps-api-v3/embed/js/56/4/intl/en_gb/init_embed.js
Requested by
Host: www.google.com
URL: https://www.google.com/maps/embed/v1/place?q=Hilton+Boston+Back+Bay%0A%0A40+Dalton+Street%2C+Boston%2C+MA+02115%2C+United+States&key=AIzaSyD09zQ9PNDNNy9TadMuzRV_UsPUoWKntt8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
019ead5b376c8e85160cab11ca5348d00b5ce67743e9de4198d6453b342acb9f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 17:30:42 GMT
content-encoding
br
x-content-type-options
nosniff
age
59558
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/maps-api-js
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
61537
x-xss-protection
0
last-modified
Tue, 12 Mar 2024 01:23:59 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="maps-api-js"
vary
Accept-Encoding, Origin
report-to
{"group":"maps-api-js","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/maps-api-js"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 13 Mar 2025 17:30:42 GMT
js
maps.googleapis.com/maps/api/ Frame A1A7
194 KB
66 KB
Script
General
Full URL
https://maps.googleapis.com/maps/api/js?client=google-maps-embed&paint_origin=&libraries=geometry,search&v=weekly&loading=async&language=en_GB&callback=onApiLoad
Requested by
Host: www.google.com
URL: https://www.google.com/maps/embed/v1/place?q=Hilton+Boston+Back+Bay%0A%0A40+Dalton+Street%2C+Boston%2C+MA+02115%2C+United+States&key=AIzaSyD09zQ9PNDNNy9TadMuzRV_UsPUoWKntt8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:829::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
scaffolding on HTTPServer2 /
Resource Hash
476b3bc7f09b6e4bb02a8b0f4765ccd212903d76d6d746940916ebd765e843dc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:20 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
scaffolding on HTTPServer2
vary
Origin, X-Origin, Referer
x-frame-options
SAMEORIGIN
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1800
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
67113
x-xss-protection
0
collect
stats.g.doubleclick.net/j/
4 B
359 B
XHR
General
Full URL
https://stats.g.doubleclick.net/j/collect?t=dc&aip=1&_r=3&v=1&_v=j101&tid=UA-38242463-64&cid=1821384544.1710410600&jid=2034608825&gjid=1043686127&_gid=270194605.1710410600&_u=YCDACEAABAAAACAAI~&z=1151740167
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:400c:c06::9d Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
84e01419bd81f32ac6df0f75f49c604fda9172000a3ae432b3c47b2a6a712d80
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
accept-language
en-GB,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
strict-transport-security
max-age=10886400; includeSubDomains; preload
date
Thu, 14 Mar 2024 10:03:20 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://tumor-myeloid-therapeutics.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
4
expires
Fri, 01 Jan 1990 00:00:00 GMT
preload-base.e36f2963.js
front.optimonk.com/
63 KB
20 KB
Script
General
Full URL
https://front.optimonk.com/preload-base.e36f2963.js
Requested by
Host: front.optimonk.com
URL: https://front.optimonk.com/public/197068/js/preload.js?
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
188.166.193.169 Frankfurt am Main, Germany, ASN14061 (DIGITALOCEAN-ASN, US),
Reverse DNS
Software
nginx /
Resource Hash
9e915b61b9781594cd6c1172aa0f62f86ff4e4c2c5af8ea7cd07d20b30563b76
Security Headers
Name Value
Strict-Transport-Security max-age=15552000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:20 GMT
strict-transport-security
max-age=15552000; includeSubDomains
x-content-type-options
nosniff
content-encoding
gzip
server
nginx
etag
W/"fc50-HmEqZKjVOSWfHhz1kpovTpDlTQ0"
x-download-options
noopen
x-dns-prefetch-control
off
x-frame-options
SAMEORIGIN
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public, max-age=604800
vary
Accept-Encoding
x-xss-protection
1; mode=block
ga-audiences
www.google.com/ads/
42 B
288 B
Image
General
Full URL
https://www.google.com/ads/ga-audiences?t=sr&aip=1&_r=4&slf_rd=1&v=1&_v=j101&tid=UA-38242463-64&cid=1821384544.1710410600&jid=2034608825&_u=YCDACEAABAAAACAAI~&z=1201760378
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 14 Mar 2024 10:03:20 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.de/ads/
42 B
408 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?t=sr&aip=1&_r=4&slf_rd=1&v=1&_v=j101&tid=UA-38242463-64&cid=1821384544.1710410600&jid=2034608825&_u=YCDACEAABAAAACAAI~&z=1201760378
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:828::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 14 Mar 2024 10:03:20 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
load
front.optimonk.com/public/197068/js/
19 KB
7 KB
XHR
General
Full URL
https://front.optimonk.com/public/197068/js/load
Requested by
Host: front.optimonk.com
URL: https://front.optimonk.com/preload-base.e36f2963.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
188.166.193.169 Frankfurt am Main, Germany, ASN14061 (DIGITALOCEAN-ASN, US),
Reverse DNS
Software
nginx /
Resource Hash
d7b34851ce12d5610d004868c113c9496ce3b05049901bb011f73995ab19120f
Security Headers
Name Value
Strict-Transport-Security max-age=15552000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
accept-language
en-GB,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36
Content-type
application/x-www-form-urlencoded

Response headers

date
Thu, 14 Mar 2024 10:03:20 GMT
strict-transport-security
max-age=15552000; includeSubDomains
x-content-type-options
nosniff
content-encoding
gzip
server
nginx
etag
W/"4b13-1O+MafB3RWlQdKguyRkIRrX2Hmc"
x-download-options
noopen
x-dns-prefetch-control
off
x-frame-options
SAMEORIGIN
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
no-cache
vary
Accept-Encoding
x-xss-protection
1; mode=block
/
jfapiprod.optimonk.com/v2/
26 B
187 B
Fetch
General
Full URL
https://jfapiprod.optimonk.com/v2/
Requested by
Host: gs-cdn.optimonk.com
URL: https://gs-cdn.optimonk.com/jfclientsdk/latest/jfclientsdk.min.js?ts=14
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.117.177.207 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
207.177.117.34.bc.googleusercontent.com
Software
/
Resource Hash
3e9b76cd18916b141392804403064f5b92bcbf054ca0b20036d44b04405fd854

Request headers

Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
accept-language
en-GB,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36
Content-Type
application/x-www-form-urlencoded;charset=UTF-8

Response headers

access-control-allow-origin
*
date
Thu, 14 Mar 2024 10:03:20 GMT
via
1.1 google
etag
W/"1a-oDk6RB3+SLV96sulj5WuSYroQto"
content-length
26
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-type
application/json; charset=utf-8
gen_204
maps.googleapis.com/maps/api/mapsjs/ Frame A1A7
3 B
46 B
XHR
General
Full URL
https://maps.googleapis.com/maps/api/mapsjs/gen_204?csp_test=true
Requested by
Host: maps.googleapis.com
URL: https://maps.googleapis.com/maps/api/js?client=google-maps-embed&paint_origin=&libraries=geometry,search&v=weekly&loading=async&language=en_GB&callback=onApiLoad
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:829::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
scaffolding on HTTPServer2 /
Resource Hash
ca3d163bab055381827226140568f3bef7eaac187cebd76878e0b63e9e442356
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:20 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
scaffolding on HTTPServer2
vary
Origin, X-Origin, Referer
x-frame-options
SAMEORIGIN
content-type
application/json; charset=UTF-8
access-control-allow-origin
https://www.google.com
access-control-expose-headers
vary,vary,vary,content-encoding,date,server,content-length
cache-control
private
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
23
x-xss-protection
0
common.js
maps.googleapis.com/maps-api-v3/api/js/56/4/intl/en_gb/ Frame A1A7
255 KB
56 KB
Script
General
Full URL
https://maps.googleapis.com/maps-api-v3/api/js/56/4/intl/en_gb/common.js
Requested by
Host: maps.googleapis.com
URL: https://maps.googleapis.com/maps/api/js?client=google-maps-embed&paint_origin=&libraries=geometry,search&v=weekly&loading=async&language=en_GB&callback=onApiLoad
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:829::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
9581dd57b6c4dac7d9624025d758d56b04f29743275222898a7608a655d0acfb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 17:30:29 GMT
content-encoding
br
x-content-type-options
nosniff
age
59571
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/maps-api-js
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
56865
x-xss-protection
0
last-modified
Tue, 12 Mar 2024 01:24:03 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="maps-api-js"
vary
Accept-Encoding, Origin
report-to
{"group":"maps-api-js","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/maps-api-js"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 13 Mar 2025 17:30:29 GMT
util.js
maps.googleapis.com/maps-api-v3/api/js/56/4/intl/en_gb/ Frame A1A7
181 KB
56 KB
Script
General
Full URL
https://maps.googleapis.com/maps-api-v3/api/js/56/4/intl/en_gb/util.js
Requested by
Host: maps.googleapis.com
URL: https://maps.googleapis.com/maps/api/js?client=google-maps-embed&paint_origin=&libraries=geometry,search&v=weekly&loading=async&language=en_GB&callback=onApiLoad
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:829::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
0d9575eb248f3e92748f8e105b97333a661b4cdc0526e46ec06d280ad7dc3583
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 17:30:29 GMT
content-encoding
br
x-content-type-options
nosniff
age
59571
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/maps-api-js
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
57130
x-xss-protection
0
last-modified
Tue, 12 Mar 2024 01:24:03 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="maps-api-js"
vary
Accept-Encoding, Origin
report-to
{"group":"maps-api-js","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/maps-api-js"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 13 Mar 2025 17:30:29 GMT
map.js
maps.googleapis.com/maps-api-v3/api/js/56/4/intl/en_gb/ Frame A1A7
72 KB
23 KB
Script
General
Full URL
https://maps.googleapis.com/maps-api-v3/api/js/56/4/intl/en_gb/map.js
Requested by
Host: maps.googleapis.com
URL: https://maps.googleapis.com/maps/api/js?client=google-maps-embed&paint_origin=&libraries=geometry,search&v=weekly&loading=async&language=en_GB&callback=onApiLoad
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:829::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
8554a6b950888777c210d22678fdb362cb4dba320e0d883087f9b7a7825c3d67
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 17:30:29 GMT
content-encoding
br
x-content-type-options
nosniff
age
59571
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/maps-api-js
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
23830
x-xss-protection
0
last-modified
Tue, 12 Mar 2024 01:24:03 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="maps-api-js"
vary
Accept-Encoding, Origin
report-to
{"group":"maps-api-js","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/maps-api-js"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 13 Mar 2025 17:30:29 GMT
overlay.js
maps.googleapis.com/maps-api-v3/api/js/56/4/intl/en_gb/ Frame A1A7
3 KB
1 KB
Script
General
Full URL
https://maps.googleapis.com/maps-api-v3/api/js/56/4/intl/en_gb/overlay.js
Requested by
Host: maps.googleapis.com
URL: https://maps.googleapis.com/maps/api/js?client=google-maps-embed&paint_origin=&libraries=geometry,search&v=weekly&loading=async&language=en_GB&callback=onApiLoad
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:829::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a821281a95a58a43f25109f180e61fc47d41aebb65925f87dc0c1ff69f8fa831
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 17:30:29 GMT
content-encoding
br
x-content-type-options
nosniff
age
59571
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/maps-api-js
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1282
x-xss-protection
0
last-modified
Tue, 12 Mar 2024 01:24:03 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="maps-api-js"
vary
Accept-Encoding, Origin
report-to
{"group":"maps-api-js","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/maps-api-js"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 13 Mar 2025 17:30:29 GMT
truncated
/ Frame A1A7
6 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
b0044d91b724bb429337d6dcd9d2332e855bc0b4452c1d3fc9beea9973017521

Request headers

accept-language
en-GB,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

Content-Type
image/svg+xml
StaticMapService.GetMapImage
maps.googleapis.com/maps/api/js/ Frame A1A7
16 KB
17 KB
Image
General
Full URL
https://maps.googleapis.com/maps/api/js/StaticMapService.GetMapImage?1m2&1i2537795&2i3103006&2e1&3u15&4m2&1u220&2u200&5m5&1e0&5sen-GB&6sus&10b1&12b1&client=google-maps-embed&token=32183
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:829::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
scaffolding on HTTPServer2 /
Resource Hash
1457223cb769e8b446c6369a9223423d385b57498c553a3efcb8fd3ce24afd87
Security Headers
Name Value
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:20 GMT
server
scaffolding on HTTPServer2
x-frame-options
SAMEORIGIN
content-type
image/png
cache-control
public, max-age=86400
server-timing
gfet4t7; dur=112
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
16753
x-xss-protection
0
expires
Fri, 15 Mar 2024 10:03:20 GMT
onion.js
maps.googleapis.com/maps-api-v3/api/js/56/4/intl/en_gb/ Frame A1A7
27 KB
9 KB
Script
General
Full URL
https://maps.googleapis.com/maps-api-v3/api/js/56/4/intl/en_gb/onion.js
Requested by
Host: maps.googleapis.com
URL: https://maps.googleapis.com/maps/api/js?client=google-maps-embed&paint_origin=&libraries=geometry,search&v=weekly&loading=async&language=en_GB&callback=onApiLoad
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:829::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
91540d8d9072ae1998185be41ccdcbfc49f387891879ce21bbb935bf20826858
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 17:30:29 GMT
content-encoding
br
x-content-type-options
nosniff
age
59571
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/maps-api-js
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
8986
x-xss-protection
0
last-modified
Tue, 12 Mar 2024 01:24:03 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="maps-api-js"
vary
Accept-Encoding, Origin
report-to
{"group":"maps-api-js","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/maps-api-js"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 13 Mar 2025 17:30:29 GMT
search_impl.js
maps.googleapis.com/maps-api-v3/api/js/56/4/intl/en_gb/ Frame A1A7
3 KB
1 KB
Script
General
Full URL
https://maps.googleapis.com/maps-api-v3/api/js/56/4/intl/en_gb/search_impl.js
Requested by
Host: maps.googleapis.com
URL: https://maps.googleapis.com/maps/api/js?client=google-maps-embed&paint_origin=&libraries=geometry,search&v=weekly&loading=async&language=en_GB&callback=onApiLoad
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:829::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
efc4dff252721e2ae8b80dbf0746ddc36f66983d9f3146011fa263b1981c8d81
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 17:30:29 GMT
content-encoding
br
x-content-type-options
nosniff
age
59571
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/maps-api-js
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1266
x-xss-protection
0
last-modified
Tue, 12 Mar 2024 01:24:03 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="maps-api-js"
vary
Accept-Encoding, Origin
report-to
{"group":"maps-api-js","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/maps-api-js"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 13 Mar 2025 17:30:29 GMT
load.fca3ec6b.js
front.optimonk.com/load.esm/
259 KB
72 KB
Script
General
Full URL
https://front.optimonk.com/load.esm/load.fca3ec6b.js
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
188.166.193.169 Frankfurt am Main, Germany, ASN14061 (DIGITALOCEAN-ASN, US),
Reverse DNS
Software
nginx /
Resource Hash
01c2dc443ba0a11751d28b094f93fb8be805a00d0364155e1bdf39742f5e0228
Security Headers
Name Value
Strict-Transport-Security max-age=15552000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Origin
https://tumor-myeloid-therapeutics.com
accept-language
en-GB,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:20 GMT
strict-transport-security
max-age=15552000; includeSubDomains
x-content-type-options
nosniff
content-encoding
gzip
server
nginx
etag
W/"40a5c-OWrTEJNYfPuueF7XUxBNqPT3HtM"
x-download-options
noopen
x-dns-prefetch-control
off
x-frame-options
SAMEORIGIN
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public, max-age=604800
vary
Accept-Encoding
x-xss-protection
1; mode=block
openhand_8_8.cur
maps.gstatic.com/mapfiles/ Frame A1A7
326 B
692 B
Image
General
Full URL
https://maps.gstatic.com/mapfiles/openhand_8_8.cur
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
7342f390b12f636d14e25f698fc5e38cf6240994dc0c07fefbbb4e78ec4d03c7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:20 GMT
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/geo-tactile
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
326
x-xss-protection
0
last-modified
Tue, 18 May 2021 19:15:00 GMT
server
sffe
report-to
{"group":"geo-tactile","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/geo-tactile"}]}
content-type
image/bmp
access-control-allow-origin
*
cache-control
private, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="geo-tactile"
expires
Thu, 14 Mar 2024 10:03:20 GMT
GetViewportInfo
maps.googleapis.com/$rpc/google.internal.maps.mapsjs.v1.MapsJsInternalService/ Frame A1A7
11 KB
2 KB
XHR
General
Full URL
https://maps.googleapis.com/$rpc/google.internal.maps.mapsjs.v1.MapsJsInternalService/GetViewportInfo
Requested by
Host: maps.googleapis.com
URL: https://maps.googleapis.com/maps/api/js?client=google-maps-embed&paint_origin=&libraries=geometry,search&v=weekly&loading=async&language=en_GB&callback=onApiLoad
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:829::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
scaffolding on HTTPServer2 /
Resource Hash
607475e4d791cfe58ad02fc1c13415e1aef62c01e6c0f15d11faeab6667c38a8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

X-Goog-Maps-Channel-Id
X-User-Agent
grpc-web-javascript/0.1
accept-language
en-GB,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36
Content-Type
application/json+protobuf
X-Goog-Maps-Client-Id
google-maps-embed
Referer
https://www.google.com/
X-Goog-Api-Key
X-Goog-Maps-API-Signature
6112
X-Goog-Maps-API-Salt
Z5yQR6qnvT

Response headers

date
Thu, 14 Mar 2024 10:03:20 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
scaffolding on HTTPServer2
vary
Origin, X-Origin, Referer
x-frame-options
SAMEORIGIN
content-type
application/json+protobuf; charset=UTF-8
access-control-allow-origin
https://www.google.com
access-control-expose-headers
vary,vary,vary,content-encoding,date,server,content-length
cache-control
private
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
2036
x-xss-protection
0
GetViewportInfo
maps.googleapis.com/$rpc/google.internal.maps.mapsjs.v1.MapsJsInternalService/ Frame
0
0
Preflight
General
Full URL
https://maps.googleapis.com/$rpc/google.internal.maps.mapsjs.v1.MapsJsInternalService/GetViewportInfo
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:829::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
scaffolding on HTTPServer2 /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type,x-goog-api-key,x-goog-maps-api-salt,x-goog-maps-api-signature,x-goog-maps-channel-id,x-goog-maps-client-id,x-user-agent
Access-Control-Request-Method
POST
Origin
https://www.google.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
content-type,x-goog-api-key,x-goog-maps-api-salt,x-goog-maps-api-signature,x-goog-maps-channel-id,x-goog-maps-client-id,x-user-agent
access-control-allow-methods
DELETE,GET,HEAD,OPTIONS,PATCH,POST,PUT
access-control-allow-origin
https://www.google.com
access-control-max-age
3600
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
content-type
text/html
date
Thu, 14 Mar 2024 10:03:20 GMT
server
scaffolding on HTTPServer2
vary
origin referer x-origin
x-content-type-options
nosniff
x-frame-options
SAMEORIGIN
x-xss-protection
0
script.js
polo.feathr.co/v1/analytics/match/
290 B
444 B
Script
General
Full URL
https://polo.feathr.co/v1/analytics/match/script.js?pk=feathr&cb=1710410600916
Requested by
Host: cdn.feathr.co
URL: https://cdn.feathr.co/js/boomerang.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::681a:f77 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
9f1387df54b1f2a7a1453677902560402da5ded73dc9e6965a7415daa25c86a2
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:21 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
DYNAMIC
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
etag
W/"65f2cb6873ab4300081d31de"
access-control-allow-methods
DELETE, GET, OPTIONS, PATCH, POST, PUT
content-type
text/javascript
access-control-allow-origin
*
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=z97bnSXmqCurt%2F9FZ%2BZORXP2sf%2BeAw9ujN3VVL8QrqTfGjIcjMrBHohTGT9gkmj9xggLeeFn1Qxo0mgl8UU%2BW2821rk6oy8qeGy%2B%2F%2F5xOjzOr91B%2Be5DCU3qpu828mMMk9SSkJSLdW2g0hRZ"}],"group":"cf-nel","max_age":604800}
cache-control
no-cache, max-age=0
access-control-allow-credentials
true
cf-ray
86436eefd98a7711-LHR
access-control-allow-headers
AccountId, Authorization, Cache-Control, Content-Type, DNT, If-Modified-Since, Keep-Alive, Range, ReportObject, ReportType, User-Agent, X-API-Key, X-Requested-With
pixel.js
polo.feathr.co/v1/accounts/5dfbace0aab76b48e7dec78e/
32 B
635 B
Script
General
Full URL
https://polo.feathr.co/v1/accounts/5dfbace0aab76b48e7dec78e/pixel.js?pk=feathr
Requested by
Host: cdn.feathr.co
URL: https://cdn.feathr.co/js/boomerang.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::681a:f77 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
eacfa4f711eaca1336ff82619c8a2d310dec11266d594fbc7e5a91259cebf848
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:21 GMT
x-content-type-options
nosniff
cf-cache-status
DYNAMIC
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
access-control-allow-methods
DELETE, GET, OPTIONS, PATCH, POST, PUT
content-type
text/javascript
access-control-allow-origin
*
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=M4sbGyZoINbVNPez1YbR%2FqA0VxrdCViVn%2B4YopZO9F0UP43jTLIGo9%2FVAvCWVYWJNMIeMn2cR27hWusXOmYJggmdWx%2FeaLLhXs23a1NPpdTBp0QDLZGnRVCCagGfCLqXkZp%2FKuJuAk7KuBHh"}],"group":"cf-nel","max_age":604800}
cache-control
must-revalidate, max-age=14400
access-control-allow-credentials
true
cf-ray
86436eefd9887711-LHR
access-control-allow-headers
AccountId, Authorization, Cache-Control, Content-Type, DNT, If-Modified-Since, Keep-Alive, Range, ReportObject, ReportType, User-Agent, X-API-Key, X-Requested-With
content-length
32
optimonk.5d3c34f7.js
front.optimonk.com/load.esm/
44 B
434 B
Script
General
Full URL
https://front.optimonk.com/load.esm/optimonk.5d3c34f7.js
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
188.166.193.169 Frankfurt am Main, Germany, ASN14061 (DIGITALOCEAN-ASN, US),
Reverse DNS
Software
nginx /
Resource Hash
304adf5eb6dd395fd121fb062ffc6d507859591fdd6dbc792b2e1fe5145ab4b9
Security Headers
Name Value
Strict-Transport-Security max-age=15552000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://front.optimonk.com/load.esm/load.fca3ec6b.js
Origin
https://tumor-myeloid-therapeutics.com
accept-language
en-GB,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:21 GMT
strict-transport-security
max-age=15552000; includeSubDomains
x-content-type-options
nosniff
content-encoding
gzip
server
nginx
etag
W/"2c-PP9xovXOpjsVds3Gr04DXoLaxdY"
x-download-options
noopen
x-frame-options
SAMEORIGIN
vary
Accept-Encoding, Accept-Encoding
content-type
application/javascript; charset=utf-8
x-dns-prefetch-control
off
access-control-allow-origin
*
cache-control
public, max-age=604800
x-xss-protection
1; mode=block
videoFactory.d9b6d53e.js
front.optimonk.com/load.esm/
171 B
533 B
Script
General
Full URL
https://front.optimonk.com/load.esm/videoFactory.d9b6d53e.js
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
188.166.193.169 Frankfurt am Main, Germany, ASN14061 (DIGITALOCEAN-ASN, US),
Reverse DNS
Software
nginx /
Resource Hash
9be2d6412eae24dc1e616cc56dcdef97920513dff73c3136b1a808622989aeb0
Security Headers
Name Value
Strict-Transport-Security max-age=15552000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://front.optimonk.com/load.esm/load.fca3ec6b.js
Origin
https://tumor-myeloid-therapeutics.com
accept-language
en-GB,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:21 GMT
strict-transport-security
max-age=15552000; includeSubDomains
x-content-type-options
nosniff
content-encoding
gzip
server
nginx
etag
W/"ab-7+puoeInCgrrEYILjxVDJpCdVEA"
x-download-options
noopen
x-frame-options
SAMEORIGIN
vary
Accept-Encoding, Accept-Encoding
content-type
application/javascript; charset=utf-8
x-dns-prefetch-control
off
access-control-allow-origin
*
cache-control
public, max-age=604800
x-xss-protection
1; mode=block
optimonk.min.css
cdn-asset.optimonk.com/bundles/wseoptimonk/css/
15 KB
3 KB
Stylesheet
General
Full URL
https://cdn-asset.optimonk.com/bundles/wseoptimonk/css/optimonk.min.css?v=b2efbc5949
Requested by
Host: front.optimonk.com
URL: https://front.optimonk.com/load.esm/load.fca3ec6b.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2400:52e0:1e00::1081:1 , Germany, ASN200325 (BUNNYCDN, SI),
Reverse DNS
Software
BunnyCDN-DE1-1081 /
Resource Hash
7bc2093fddc50bfc2e60a164b34bff71975b3d3d467d8d6b657f4c6324b1a76a
Security Headers
Name Value
Strict-Transport-Security max-age=15552000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:21 GMT
strict-transport-security
max-age=15552000; includeSubDomains
x-content-type-options
nosniff
content-encoding
br
cdn-edgestorageid
1082
x-dns-prefetch-control
off
cdn-cachedat
03/03/2024 13:09:36
cdn-pullzone
580384
x-xss-protection
1; mode=block
server
BunnyCDN-DE1-1081
cdn-proxyver
1.04
cdn-requestpullcode
200
etag
W/"3c5f-+aJzZURpEvNsmjMFlnXjMeoe03w"
x-download-options
noopen
vary
Accept-Encoding, Accept-Encoding
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cdn-cache
HIT
cdn-uid
03887a3a-e2eb-4f9c-b547-bb29001e27f6
access-control-expose-headers
Server, x-goog-meta-frames, Content-Length, Content-Type, Range, X-Requested-With, If-Modified-Since, If-None-Match
cache-control
public, max-age=2592000
cdn-requestid
42309d79f831fd01c99290587c626240
cdn-requestcountrycode
DE
access-control-allow-headers
Server, x-goog-meta-frames, Content-Length, Content-Type, Range, X-Requested-With, If-Modified-Since, If-None-Match
cdn-status
200
cdn-requestpullsuccess
True
/
jfapiprod.optimonk.com/v2/
26 B
76 B
Fetch
General
Full URL
https://jfapiprod.optimonk.com/v2/
Requested by
Host: gs-cdn.optimonk.com
URL: https://gs-cdn.optimonk.com/jfclientsdk/latest/jfclientsdk.min.js?ts=14
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.117.177.207 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
207.177.117.34.bc.googleusercontent.com
Software
/
Resource Hash
3e9b76cd18916b141392804403064f5b92bcbf054ca0b20036d44b04405fd854

Request headers

Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
accept-language
en-GB,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36
Content-Type
application/x-www-form-urlencoded;charset=UTF-8

Response headers

access-control-allow-origin
*
date
Thu, 14 Mar 2024 10:03:21 GMT
via
1.1 google
etag
W/"1a-oDk6RB3+SLV96sulj5WuSYroQto"
content-length
26
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-type
application/json; charset=utf-8
65c392f4a9988b00245fd55d.html
cdn-renderer.optimonk.com/ssr/197068/ Frame 7964
48 KB
7 KB
XHR
General
Full URL
https://cdn-renderer.optimonk.com/ssr/197068/65c392f4a9988b00245fd55d.html?v=1707385710
Requested by
Host: front.optimonk.com
URL: https://front.optimonk.com/load.esm/load.fca3ec6b.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2400:52e0:1e00::1080:1 , Germany, ASN200325 (BUNNYCDN, SI),
Reverse DNS
Software
BunnyCDN-DE1-1080 /
Resource Hash
0ffdaad11a8c6489d638462f5d917b552f78ea69b379b3e2da00670c3800dda8
Security Headers
Name Value
Strict-Transport-Security max-age=15552000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
en-GB,en;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:21 GMT
strict-transport-security
max-age=15552000; includeSubDomains
x-content-type-options
nosniff
content-encoding
br
x-permitted-cross-domain-policies
none
cdn-edgestorageid
1081
x-dns-prefetch-control
off
cdn-cachedat
02/14/2024 09:03:37
cdn-pullzone
736120
x-xss-protection
0
referrer-policy
no-referrer
server
BunnyCDN-DE1-1080
cdn-proxyver
1.04
cdn-requestpullcode
200
etag
W/"c160-luUcpIHxJcDkP9Axv8ir8x0eg3A"
x-download-options
noopen
expect-ct
max-age=0
vary
Accept-Encoding
content-type
text/html; charset=utf-8
x-frame-options
SAMEORIGIN
access-control-allow-origin
https://tumor-myeloid-therapeutics.com
cdn-uid
03887a3a-e2eb-4f9c-b547-bb29001e27f6
cdn-cache
HIT
access-control-allow-credentials
true
access-control-expose-headers
Server, x-goog-meta-frames, Content-Length, Content-Type, Range, X-Requested-With, If-Modified-Since, If-None-Match
cache-control
public, max-age=2592000
cdn-requestid
904f71d23e4823c0cc8360433921c220
cdn-requestcountrycode
DE
access-control-allow-headers
Server, x-goog-meta-frames, Content-Length, Content-Type, Range, X-Requested-With, If-Modified-Since, If-None-Match
cdn-status
200
cdn-requestpullsuccess
True
generic
match.adsrvr.org/track/cmf/
70 B
149 B
Image
General
Full URL
https://match.adsrvr.org/track/cmf/generic?ttd_pid=6fgi4r1&ttd_tpi=1&ttd_puid=65f2cb6873ab4300081d31de&gdpr=0
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.71.131.137 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
a6370ebea231e0c9a.awsglobalaccelerator.com
Software
Kestrel /
Resource Hash
8d70b3e6badb6973663b398d297bb32eaedd08826a1af98d0a1cfce5324ffce0

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:21 GMT
server
Kestrel
content-length
70
content-type
image/gif
CountryHelper.d4b04fb4.js
front.optimonk.com/load.esm/
6 KB
4 KB
Script
General
Full URL
https://front.optimonk.com/load.esm/CountryHelper.d4b04fb4.js
Requested by
Host: front.optimonk.com
URL: https://front.optimonk.com/load.esm/load.fca3ec6b.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
188.166.193.169 Frankfurt am Main, Germany, ASN14061 (DIGITALOCEAN-ASN, US),
Reverse DNS
Software
nginx /
Resource Hash
064961d82e13c1e23df87a479af2d81f6791fbbb090f2ec8f0c7733500e60a3c
Security Headers
Name Value
Strict-Transport-Security max-age=15552000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://front.optimonk.com/load.esm/load.fca3ec6b.js
Origin
https://tumor-myeloid-therapeutics.com
accept-language
en-GB,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:21 GMT
strict-transport-security
max-age=15552000; includeSubDomains
x-content-type-options
nosniff
content-encoding
gzip
server
nginx
etag
W/"18be-X9El92KGSavvsmRIRbhNANA/U1A"
x-download-options
noopen
x-dns-prefetch-control
off
x-frame-options
SAMEORIGIN
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public, max-age=604800
vary
Accept-Encoding
x-xss-protection
1; mode=block
6b0e5876-b940-11e_1707382319845.png
editor-upload-cdn.optimonk.com/userImages/197068/65c392f4a9988b00245fd55d/
27 KB
27 KB
Image
General
Full URL
https://editor-upload-cdn.optimonk.com/userImages/197068/65c392f4a9988b00245fd55d/6b0e5876-b940-11e_1707382319845.png
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2400:52e0:1e00::1081:1 , Germany, ASN200325 (BUNNYCDN, SI),
Reverse DNS
Software
BunnyCDN-DE1-1081 /
Resource Hash
5dcee4ae4aa002273404be75959360070c1d3a5d54cdb5733fe20879b4bf2b99

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:21 GMT
x-downloadsize
18418
cdn-edgestorageid
1081
x-bo-processingtime
1
cdn-cachedat
02/14/2024 10:31:23
cdn-pullzone
573677
content-length
27286
x-bo-server
DE-243
last-modified
Wed, 14 Feb 2024 10:31:23 GMT
server
BunnyCDN-DE1-1081
cdn-proxyver
1.04
cdn-requestpullcode
200
x-bo-origindownloadtime
175
content-type
image/webp
access-control-allow-origin
*
cdn-cache
HIT
cdn-uid
03887a3a-e2eb-4f9c-b547-bb29001e27f6
access-control-expose-headers
Server, x-goog-meta-frames, Content-Length, Content-Type, Range, X-Requested-With, If-Modified-Since, If-None-Match
cache-control
public, max-age=86400
x-bo-compressionratio
0%
cdn-requestid
363b6ed2cde2b946697ebd8ea5432d21
cdn-requestcountrycode
DE
access-control-allow-headers
Server, x-goog-meta-frames, Content-Length, Content-Type, Range, X-Requested-With, If-Modified-Since, If-None-Match
cdn-status
200
cdn-requestpullsuccess
True
script.js
polo.feathr.co/v1/analytics/match/
290 B
405 B
Script
General
Full URL
https://polo.feathr.co/v1/analytics/match/script.js?pk=feathr&cb=1710410601324
Requested by
Host: cdn.feathr.co
URL: https://cdn.feathr.co/js/boomerang.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::681a:f77 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
9f1387df54b1f2a7a1453677902560402da5ded73dc9e6965a7415daa25c86a2
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:21 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
DYNAMIC
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
etag
W/"65f2cb6873ab4300081d31de"
access-control-allow-methods
DELETE, GET, OPTIONS, PATCH, POST, PUT
content-type
text/javascript
access-control-allow-origin
*
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=U60%2BFZ%2BSsmgmb%2BFKdF1IK7LispLb8sQ2iqXOMS14gdKjWtbp%2FVBj3RGjulb%2BCXDsHRjWVHoCMem%2FeXptxHwm0ptilyva2kqY5j1S3r3hwK7FRwyzXQ9dGhC2mdvOCzqyWz6wYrOmK1r1VRxJ"}],"group":"cf-nel","max_age":604800}
cache-control
no-cache, max-age=0
access-control-allow-credentials
true
cf-ray
86436ef26c457711-LHR
access-control-allow-headers
AccountId, Authorization, Cache-Control, Content-Type, DNT, If-Modified-Since, Keep-Alive, Range, ReportObject, ReportType, User-Agent, X-API-Key, X-Requested-With
intlTelInput.min.js
cdn-asset.optimonk.com/vendors/
27 KB
11 KB
Script
General
Full URL
https://cdn-asset.optimonk.com/vendors/intlTelInput.min.js?v=d0ca14b56a
Requested by
Host: front.optimonk.com
URL: https://front.optimonk.com/load.esm/load.fca3ec6b.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2400:52e0:1e00::1081:1 , Germany, ASN200325 (BUNNYCDN, SI),
Reverse DNS
Software
BunnyCDN-DE1-1081 /
Resource Hash
b7e134a83ad8f8daf2f1fc66b58a626d70b1f8340d0424de49dccf939d8f2557
Security Headers
Name Value
Strict-Transport-Security max-age=15552000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:21 GMT
strict-transport-security
max-age=15552000; includeSubDomains
x-content-type-options
nosniff
content-encoding
br
cdn-edgestorageid
1082
x-dns-prefetch-control
off
cdn-cachedat
07/07/2023 01:55:26
cdn-pullzone
580384
x-xss-protection
1; mode=block
server
BunnyCDN-DE1-1081
cdn-proxyver
1.03
cdn-requestpullcode
200
etag
W/"6a44-cXcp7KiLQB5OV91JpevUTpvWGz0"
x-download-options
noopen
vary
Accept-Encoding, Accept-Encoding
x-frame-options
SAMEORIGIN
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cdn-cache
HIT
cdn-uid
03887a3a-e2eb-4f9c-b547-bb29001e27f6
cache-control
public, max-age=2592000
cdn-requestid
32b24916e9e10528cf298a7bb2725784
cdn-requestcountrycode
DE
cdn-status
200
cdn-requestpullsuccess
True
utils.js
cdnjs.cloudflare.com/ajax/libs/intl-tel-input/15.0.0/js/
228 KB
43 KB
Script
General
Full URL
https://cdnjs.cloudflare.com/ajax/libs/intl-tel-input/15.0.0/js/utils.js
Requested by
Host: cdn-asset.optimonk.com
URL: https://cdn-asset.optimonk.com/vendors/intlTelInput.min.js?v=d0ca14b56a
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6811:180e , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e5277eaf274835757d6682660675f6c3af0d95f8462d007483c881730f1a95e2
Security Headers
Name Value
Strict-Transport-Security max-age=15780000
X-Content-Type-Options nosniff

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:21 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
strict-transport-security
max-age=15780000
age
226953
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
content-length
43396
last-modified
Mon, 04 May 2020 16:11:18 GMT
server
cloudflare
cf-cdnjs-via
cfworker/kv
etag
"5eb03ea6-391c8"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=XnVimwcpjfE26aR9j7p2asRIKE78yG3JpAOirneeEkafGSFTb%2BObE8DbD7w3cn0ovQjyqbWUkKOUKorflAk9X9ekRrkndV0%2FvKZbDKTNV8uI2Rx%2FV1s2f1QUplzlnzkLRwilOEBXpPD0X3zzvIknOJTy"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public, max-age=30672000
accept-ranges
bytes
timing-allow-origin
*
cf-ray
86436ef3a91860e2-LHR
expires
Tue, 04 Mar 2025 10:03:21 GMT
pd.js
pi.pardot.com/
5 KB
2 KB
Script
General
Full URL
https://pi.pardot.com/pd.js
Requested by
Host: tumor-myeloid-therapeutics.com
URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.237.219.119 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-219-119.compute-1.amazonaws.com
Software
/
Resource Hash
41402adfc915ad6dfd6328c06c8038763d25fe603e63beba4a2638a2bbc03136

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

Date
Thu, 14 Mar 2024 10:03:21 GMT
content-encoding
gzip
X-Pardot-Route
16b0ab393667a33fe86adedc3141e88c
last-modified
Wed, 13 Mar 2024 05:19:07 GMT
etag
"15f4-gzip"
vary
Accept-Encoding,User-Agent
Content-Type
application/javascript
cache-control
max-age=63072000
Connection
keep-alive
accept-ranges
bytes
Content-Length
1988
expires
Sat, 14 Mar 2026 10:03:21 GMT
analytics
pi.pardot.com/
1 KB
2 KB
Script
General
Full URL
https://pi.pardot.com/analytics?ver=3&visitor_id=&visitor_id_sign=&pi_opt_in=&campaign_id=147403&account_id=449062&title=4th%20Tumor%20Myeloid-Directed%20Therapies%20Summit%202024%20%7C%20Register&url=https%3A%2F%2Ftumor-myeloid-therapeutics.com%2Ftake-part%2Fregister%2F%3Futm_source%3Dexternal%26utm_medium%3Demail%26utm_campaign%3Dlaunch%26utm_content%3Dmedia-partner%2Fpharma-journalist%2Fpaid%2Fmarch%2Fem-01%2Fev-47521&referrer=&utm_campaign=launch&utm_medium=email&utm_source=external&utm_content=media-partner%2Fpharma-journalist%2Fpaid%2Fmarch%2Fem-01%2Fev-47521
Requested by
Host: pi.pardot.com
URL: https://pi.pardot.com/pd.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.237.219.119 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-219-119.compute-1.amazonaws.com
Software
/
Resource Hash
51b2fd2ce3912cf27f51be2081360f9f6fafb6fecf26d175d7fca6c0aae9ac0b
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

pragma
no-cache
Date
Thu, 14 Mar 2024 10:03:22 GMT
strict-transport-security
max-age=31536000; includeSubDomains
content-encoding
gzip
X-Pardot-Route
9b06e8e2308c32c7bf9ba8adfb7be2e1
x-pardot-rsp
0/0/1
vary
Accept-Encoding,User-Agent
Content-Type
text/javascript; charset=utf-8
p3p
CP="NOI DSP COR CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT", policyref="/w3c/p3p.xml", CP="NOI DSP COR CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT", policyref="/w3c/p3p.xml"
cache-control
no-store, no-cache, must-revalidate
Connection
keep-alive
Content-Length
553
expires
Thu, 19 Nov 1981 08:52:00 GMT
analytics
info.hansonwade.com/
50 B
1018 B
Script
General
Full URL
https://info.hansonwade.com/analytics?conly=true&visitor_id=891925584&visitor_id_sign=18906febceb4956cb5ec8d9896c858c3db43009f1d3c14a8d495a207ddbb6c8f4c6144aaa8acc937cfabd77b74962b7b6f50761a&pi_opt_in=&campaign_id=147403&account_id=449062&title=4th%20Tumor%20Myeloid-Directed%20Therapies%20Summit%202024%20%7C%20Register&url=https%3A%2F%2Ftumor-myeloid-therapeutics.com%2Ftake-part%2Fregister%2F%3Futm_source%3Dexternal%26utm_medium%3Demail%26utm_campaign%3Dlaunch%26utm_content%3Dmedia-partner%2Fpharma-journalist%2Fpaid%2Fmarch%2Fem-01%2Fev-47521&referrer=&utm_campaign=launch&utm_medium=email&utm_source=external&utm_content=media-partner%2Fpharma-journalist%2Fpaid%2Fmarch%2Fem-01%2Fev-47521
Requested by
Host: pi.pardot.com
URL: https://pi.pardot.com/analytics?ver=3&visitor_id=&visitor_id_sign=&pi_opt_in=&campaign_id=147403&account_id=449062&title=4th%20Tumor%20Myeloid-Directed%20Therapies%20Summit%202024%20%7C%20Register&url=https%3A%2F%2Ftumor-myeloid-therapeutics.com%2Ftake-part%2Fregister%2F%3Futm_source%3Dexternal%26utm_medium%3Demail%26utm_campaign%3Dlaunch%26utm_content%3Dmedia-partner%2Fpharma-journalist%2Fpaid%2Fmarch%2Fem-01%2Fev-47521&referrer=&utm_campaign=launch&utm_medium=email&utm_source=external&utm_content=media-partner%2Fpharma-journalist%2Fpaid%2Fmarch%2Fem-01%2Fev-47521
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.215.172.219 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-215-172-219.compute-1.amazonaws.com
Software
/
Resource Hash
dcf430710cdd1359115293f45d5023b2a560aef8a2c1e59d578b8b1e10a216d3

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

pragma
no-cache
Date
Thu, 14 Mar 2024 10:03:22 GMT
X-Pardot-Route
9b06e8e2308c32c7bf9ba8adfb7be2e1
x-pardot-rsp
0/0/1
vary
User-Agent
Content-Type
text/javascript; charset=utf-8
p3p
CP="NOI DSP COR CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT", policyref="/w3c/p3p.xml", CP="NOI DSP COR CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT", policyref="/w3c/p3p.xml"
cache-control
no-store, no-cache, must-revalidate
Connection
keep-alive
Content-Length
50
expires
Thu, 19 Nov 1981 08:52:00 GMT
om.base.3f57ac473bbed02a7c2e.css
cdn-asset.optimonk.com/assets/css/
278 KB
31 KB
Stylesheet
General
Full URL
https://cdn-asset.optimonk.com/assets/css/om.base.3f57ac473bbed02a7c2e.css
Requested by
Host: front.optimonk.com
URL: https://front.optimonk.com/load.esm/load.fca3ec6b.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2400:52e0:1e00::1081:1 , Germany, ASN200325 (BUNNYCDN, SI),
Reverse DNS
Software
BunnyCDN-DE1-1081 /
Resource Hash
bbeb8ebb638c4dcd888ad39f76b64bd7fddab0d84befb1fcf5df94f94cb94e40
Security Headers
Name Value
Strict-Transport-Security max-age=15552000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:24 GMT
strict-transport-security
max-age=15552000; includeSubDomains
x-content-type-options
nosniff
content-encoding
br
cdn-edgestorageid
1081
x-dns-prefetch-control
off
cdn-cachedat
03/14/2024 08:55:14
cdn-pullzone
580384
x-xss-protection
1; mode=block
server
BunnyCDN-DE1-1081
cdn-proxyver
1.04
cdn-requestpullcode
200
etag
W/"45997-ffY8t4g9ylLCczfcT9Pw6/vQo+w"
x-download-options
noopen
vary
Accept-Encoding, Accept-Encoding
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cdn-cache
HIT
cdn-uid
03887a3a-e2eb-4f9c-b547-bb29001e27f6
access-control-expose-headers
Server, x-goog-meta-frames, Content-Length, Content-Type, Range, X-Requested-With, If-Modified-Since, If-None-Match
cache-control
public, max-age=2592000
cdn-requestid
1aeb152091ad6fdd959b3b05c0fe7c62
cdn-requestcountrycode
DE
access-control-allow-headers
Server, x-goog-meta-frames, Content-Length, Content-Type, Range, X-Requested-With, If-Modified-Since, If-None-Match
cdn-status
200
cdn-requestpullsuccess
True
css
fonts.googleapis.com/
14 KB
2 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Gruppo:400%7CMontserrat:400,700%7COpen+Sans:400%7CRaleway:800,800i&display=swap
Requested by
Host: front.optimonk.com
URL: https://front.optimonk.com/load.esm/load.fca3ec6b.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:803::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
363aaa6560b27a46de5155c7198de264ddffb5c39b877d51da175556d0d5fb10
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
date
Thu, 14 Mar 2024 10:03:24 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Thu, 14 Mar 2024 10:03:24 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Thu, 14 Mar 2024 10:03:24 GMT
BG%202_1707382059517.png
editor-upload-cdn.optimonk.com/userImages/197068/65c392f4a9988b00245fd55d/
22 KB
22 KB
Image
General
Full URL
https://editor-upload-cdn.optimonk.com/userImages/197068/65c392f4a9988b00245fd55d/BG%202_1707382059517.png
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2400:52e0:1e00::1081:1 , Germany, ASN200325 (BUNNYCDN, SI),
Reverse DNS
Software
BunnyCDN-DE1-1081 /
Resource Hash
dfd0a05f6d0bb87c83c8cd70eae4f7b8796b8959cd54e33b35dc0a697be5ffe4

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:24 GMT
x-downloadsize
114944
cdn-edgestorageid
1081
x-bo-processingtime
3
cdn-cachedat
02/14/2024 10:31:27
cdn-pullzone
573677
content-length
22094
x-bo-server
DE-224
last-modified
Wed, 14 Feb 2024 10:31:26 GMT
server
BunnyCDN-DE1-1081
cdn-proxyver
1.04
cdn-requestpullcode
200
x-bo-origindownloadtime
486
content-type
image/webp
access-control-allow-origin
*
cdn-cache
HIT
cdn-uid
03887a3a-e2eb-4f9c-b547-bb29001e27f6
access-control-expose-headers
Server, x-goog-meta-frames, Content-Length, Content-Type, Range, X-Requested-With, If-Modified-Since, If-None-Match
cache-control
public, max-age=86400
x-bo-compressionratio
80.78%
cdn-requestid
fd0d29e01fdab5e1740e75ba307fc535
cdn-requestcountrycode
DE
access-control-allow-headers
Server, x-goog-meta-frames, Content-Length, Content-Type, Range, X-Requested-With, If-Modified-Since, If-None-Match
cdn-status
200
cdn-requestpullsuccess
True
HW220922%2032585%20-%20_1696842403725.jpg
editor-upload-cdn.optimonk.com/userImages/197068/6523c22a553abc002476e8f0/
139 KB
140 KB
Image
General
Full URL
https://editor-upload-cdn.optimonk.com/userImages/197068/6523c22a553abc002476e8f0/HW220922%2032585%20-%20_1696842403725.jpg
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2400:52e0:1e00::1081:1 , Germany, ASN200325 (BUNNYCDN, SI),
Reverse DNS
Software
BunnyCDN-DE1-1081 /
Resource Hash
81b230a8722902cda6f8c278b8891f4f6638fd7e795e9ed617004ab62d63f37c

Request headers

accept-language
en-GB,en;q=0.9
Referer
https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Thu, 14 Mar 2024 10:03:24 GMT
x-downloadsize
309229
cdn-edgestorageid
1080
x-bo-processingtime
205
cdn-cachedat
10/09/2023 13:38:24
cdn-pullzone
573677
content-length
142478
x-bo-server
DE-42
last-modified
Mon, 09 Oct 2023 13:38:23 GMT
server
BunnyCDN-DE1-1081
cdn-proxyver
1.04
cdn-requestpullcode
200
x-bo-origindownloadtime
282
content-type
image/webp
access-control-allow-origin
*
cdn-cache
HIT
cdn-uid
03887a3a-e2eb-4f9c-b547-bb29001e27f6
access-control-expose-headers
Server, x-goog-meta-frames, Content-Length, Content-Type, Range, X-Requested-With, If-Modified-Since, If-None-Match
cache-control
public, max-age=86400
x-bo-compressionratio
53.92%
cdn-requestid
3e658e10881f1aa23e9224c106681926
cdn-requestcountrycode
DE
access-control-allow-headers
Server, x-goog-meta-frames, Content-Length, Content-Type, Range, X-Requested-With, If-Modified-Since, If-None-Match
cdn-status
200
cdn-requestpullsuccess
True
WwkfxPmzE06v_ZW1XnrB.woff2
fonts.gstatic.com/s/gruppo/v21/
23 KB
23 KB
Font
General
Full URL
https://fonts.gstatic.com/s/gruppo/v21/WwkfxPmzE06v_ZW1XnrB.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Gruppo:400%7CMontserrat:400,700%7COpen+Sans:400%7CRaleway:800,800i&display=swap
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2003 -, , ASN (),
Reverse DNS
Software
sffe /
Resource Hash
e598bdc4d27b7b6eecde3ae3b6fb268b9de4294320e220202aaa13335fd7f7cb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://tumor-myeloid-therapeutics.com
accept-language
en-GB,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Tue, 12 Mar 2024 01:26:37 GMT
x-content-type-options
nosniff
age
203808
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
23080
x-xss-protection
0
last-modified
Thu, 24 Aug 2023 20:12:08 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Wed, 12 Mar 2025 01:26:37 GMT
JTUSjIg1_i6t8kCHKm459Wlhyw.woff2
fonts.gstatic.com/s/montserrat/v26/
32 KB
32 KB
Font
General
Full URL
https://fonts.gstatic.com/s/montserrat/v26/JTUSjIg1_i6t8kCHKm459Wlhyw.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Gruppo:400%7CMontserrat:400,700%7COpen+Sans:400%7CRaleway:800,800i&display=swap
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2003 -, , ASN (),
Reverse DNS
Software
sffe /
Resource Hash
bb2f90081933c0f2475883ca2c5cfee94e96d7314a09433fffc42e37f4cffd3b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://tumor-myeloid-therapeutics.com
accept-language
en-GB,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Tue, 12 Mar 2024 06:41:12 GMT
x-content-type-options
nosniff
age
184933
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
33092
x-xss-protection
0
last-modified
Wed, 13 Sep 2023 22:51:58 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Wed, 12 Mar 2025 06:41:12 GMT
JTUSjIg1_i6t8kCHKm459Wlhyw.woff2
fonts.gstatic.com/s/montserrat/v26/
32 KB
32 KB
Font
General
Full URL
https://fonts.gstatic.com/s/montserrat/v26/JTUSjIg1_i6t8kCHKm459Wlhyw.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Gruppo:400%7CMontserrat:400,700%7COpen+Sans:400%7CRaleway:800,800i&display=swap
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2003 -, , ASN (),
Reverse DNS
Software
sffe /
Resource Hash
bb2f90081933c0f2475883ca2c5cfee94e96d7314a09433fffc42e37f4cffd3b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://tumor-myeloid-therapeutics.com
accept-language
en-GB,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Tue, 12 Mar 2024 06:41:12 GMT
x-content-type-options
nosniff
age
184933
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
33092
x-xss-protection
0
last-modified
Wed, 13 Sep 2023 22:51:58 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Wed, 12 Mar 2025 06:41:12 GMT
memSYaGs126MiZpBA-UvWbX2vVnXBbObj2OVZyOOSr4dVJWUgsjZ0B4gaVI.woff2
fonts.gstatic.com/s/opensans/v40/
18 KB
18 KB
Font
General
Full URL
https://fonts.gstatic.com/s/opensans/v40/memSYaGs126MiZpBA-UvWbX2vVnXBbObj2OVZyOOSr4dVJWUgsjZ0B4gaVI.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Gruppo:400%7CMontserrat:400,700%7COpen+Sans:400%7CRaleway:800,800i&display=swap
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2003 -, , ASN (),
Reverse DNS
Software
sffe /
Resource Hash
e7af9d60d875eb1c1b1037bbbfdec41fcb096d0ebcf98a48717ad8b07906ced6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://tumor-myeloid-therapeutics.com
accept-language
en-GB,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 02:10:54 GMT
x-content-type-options
nosniff
age
114751
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
18668
x-xss-protection
0
last-modified
Thu, 14 Dec 2023 02:00:39 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Thu, 13 Mar 2025 02:10:54 GMT
1Ptxg8zYS_SKggPN4iEgvnHyvveLxVtapbCIPrE.woff2
fonts.gstatic.com/s/raleway/v29/
22 KB
23 KB
Font
General
Full URL
https://fonts.gstatic.com/s/raleway/v29/1Ptxg8zYS_SKggPN4iEgvnHyvveLxVtapbCIPrE.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Gruppo:400%7CMontserrat:400,700%7COpen+Sans:400%7CRaleway:800,800i&display=swap
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2003 -, , ASN (),
Reverse DNS
Software
sffe /
Resource Hash
cdb9f92dad1013de7fd56d59eba4c69f50bbb446cc03d3cf03e376b582a51a2b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://tumor-myeloid-therapeutics.com
accept-language
en-GB,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.128 Safari/537.36

Response headers

date
Wed, 13 Mar 2024 02:08:50 GMT
x-content-type-options
nosniff
age
114875
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
22680
x-xss-protection
0
last-modified
Wed, 13 Sep 2023 23:23:26 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Thu, 13 Mar 2025 02:08:50 GMT
crumb
polo.feathr.co/v1/analytics/
0
0

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
hansonwade.com
URL
http://hansonwade.com/
Domain
hansonwade.com
URL
http://hansonwade.com/
Domain
polo.feathr.co
URL
https://polo.feathr.co/v1/analytics/crumb?cb=1710410605412&a_id=5dfbace0aab76b48e7dec78e&f_id=65f2cb6873ab4300081d31de&ses_id=65f2cb68651b89de615c01a3&flvr=page_view&loc_url=https%3A%2F%2Ftumor-myeloid-therapeutics.com%2Ftake-part%2Fregister%2F%3Futm_source%3Dexternal%26utm_medium%3Demail%26utm_campaign%3Dlaunch%26utm_content%3Dmedia-partner%2Fpharma-journalist%2Fpaid%2Fmarch%2Fem-01%2Fev-47521&s_w=1600&s_h=1200&b_w=1600&b_h=1200&cust_params=e30=&utm_params=eyJ1dG1fc291cmNlIjoiZXh0ZXJuYWwiLCJ1dG1fbWVkaXVtIjoiZW1haWwiLCJ1dG1fY2FtcGFpZ24iOiJsYXVuY2giLCJ1dG1fY29udGVudCI6Im1lZGlhLXBhcnRuZXIvcGhhcm1hLWpvdXJuYWxpc3QvcGFpZC9tYXJjaC9lbS0wMS9ldi00NzUyMSJ9

Verdicts & Comments Add Verdict or Comment

73 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| 2 function| share_fb function| share_twitter function| share_linkedin object| _wpemojiSettings undefined| $ function| jQuery object| cnArgs object| dataLayer function| EvEmitter function| imagesLoaded object| themeopts object| FLTheme string| wpAjaxUrl string| flBuilderUrl object| FLBuilderLayoutConfig function| FLBuilderPricingTable function| FLBuilderCountdown object| FLBuilderCountdownIntervals object| FLBuilderLayout function| FLBuilderMenu object| FLThemeBuilderHeaderLayout boolean| ipad string| _fl_string_to_slug_regex object| twemoji object| wp object| OptiMonk object| OptiMonkEmbedded object| OptiMonkRegistry boolean| OptiMonkPreloadStarted object| google_tag_manager object| google_tag_data string| GoogleAnalyticsObject function| ga function| receiveMessage function| feathr function| FeathrBoomerang string| piAId string| piCId string| piHostname function| onYouTubeIframeAPIReady object| gaGlobal object| gaplugins object| gaData undefined| feathr_account_id object| __feathrs boolean| initialized object| omPreloadScript function| ns function| generateUUID function| getVersionedFile function| getStaticUrlFor function| getAssetUrlFor object| webpackChunkJFClientSDK object| JFClientSDK undefined| Optimonk object| intlTelInputGlobals object| intlTelInputUtils function| checkNamespace function| getPardotUrl function| piTracker function| piGetParameter function| piGetCookie function| piSetCookie string| piVersion number| piScriptNum object| piScriptObj object| pi number| c_start string| property function| piResponse

18 Cookies

Domain/Path Name / Value
tumor-myeloid-therapeutics.com/ Name: optiMonkClientId
Value: 9e4bcbd2-325d-3dd7-0aae-b35758ade009
.tumor-myeloid-therapeutics.com/ Name: _gcl_au
Value: 1.1.1873835453.1710410600
.tumor-myeloid-therapeutics.com/ Name: _ga_ED2F8XSC1V
Value: GS1.1.1710410600.1.0.1710410600.0.0.0
tumor-myeloid-therapeutics.com/ Name: optiMonkSession
Value: 1710410600
.tumor-myeloid-therapeutics.com/ Name: _ga
Value: GA1.2.1821384544.1710410600
.tumor-myeloid-therapeutics.com/ Name: _gid
Value: GA1.2.270194605.1710410600
.tumor-myeloid-therapeutics.com/ Name: _gat_UA-38242463-64
Value: 1
.tumor-myeloid-therapeutics.com/ Name: feathr_session_id
Value: 65f2cb68651b89de615c01a3
tumor-myeloid-therapeutics.com/ Name: optiMonkEmbedded197068
Value: N4IgFghgzgMglgWzgFwEoFMIGMzoCYgBcAZhADZToC+QA===
tumor-myeloid-therapeutics.com/ Name: optiMonkClient
Value: N4IgjAnA7ADAbADhALlAYwIYuAXwDQgBmAbimFGDACyVwwwEA2py5lN89BAdgPYAOLMDhxA=
.feathr.co/ Name: f_id
Value: 65f2cb6873ab4300081d31de
.pardot.com/ Name: visitor_id448062
Value: 891925584
.pardot.com/ Name: visitor_id448062-hash
Value: 18906febceb4956cb5ec8d9896c858c3db43009f1d3c14a8d495a207ddbb6c8f4c6144aaa8acc937cfabd77b74962b7b6f50761a
pi.pardot.com/ Name: lpv448062
Value: aHR0cHM6Ly90dW1vci1teWVsb2lkLXRoZXJhcGV1dGljcy5jb20vdGFrZS1wYXJ0L3JlZ2lzdGVyLz91dG1fc291cmNlPWV4dGVybmFsJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPWxhdW5jaCZ1dG1fY29udGVudD1tZWRpYS1wYXJ0bmVyL3BoYXJtYS1qb3VybmFsaXN0L3BhaWQvbWFyY2gvZW0tMDEvZXYtNDc1MjE%3D
tumor-myeloid-therapeutics.com/ Name: visitor_id448062
Value: 891925584
tumor-myeloid-therapeutics.com/ Name: visitor_id448062-hash
Value: 18906febceb4956cb5ec8d9896c858c3db43009f1d3c14a8d495a207ddbb6c8f4c6144aaa8acc937cfabd77b74962b7b6f50761a
info.hansonwade.com/ Name: visitor_id448062
Value: 891925584
info.hansonwade.com/ Name: visitor_id448062-hash
Value: 18906febceb4956cb5ec8d9896c858c3db43009f1d3c14a8d495a207ddbb6c8f4c6144aaa8acc937cfabd77b74962b7b6f50761a

18 Console Messages

Source Level URL
Text
security warning
Message:
Error with Permissions-Policy header: Unrecognized feature: 'ambient-light-sensor'.
security warning
Message:
Error with Permissions-Policy header: Unrecognized feature: 'battery'.
security warning
Message:
Error with Permissions-Policy header: Unrecognized feature: 'document-domain'.
security warning
Message:
Error with Permissions-Policy header: Unrecognized feature: 'execution-while-not-rendered'.
security warning
Message:
Error with Permissions-Policy header: Unrecognized feature: 'execution-while-out-of-viewport'.
security warning
Message:
Error with Permissions-Policy header: Unrecognized feature: 'navigation-override'.
security warning
Message:
Error with Permissions-Policy header: Unrecognized feature: 'web-share'.
security error URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Message:
Mixed Content: The page at 'https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521' was loaded over HTTPS, but requested an insecure script 'http://hansonwade.com/'. This request has been blocked; the content must be served over HTTPS.
security error URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Message:
Mixed Content: The page at 'https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521' was loaded over HTTPS, but requested an insecure script 'http://hansonwade.com/'. This request has been blocked; the content must be served over HTTPS.
other warning URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://tumor-myeloid-therapeutics.com/take-part/register/?utm_source=external&utm_medium=email&utm_campaign=launch&utm_content=media-partner/pharma-journalist/paid/march/em-01/ev-47521
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

cdn-account.optimonk.com
cdn-asset.optimonk.com
cdn-renderer.optimonk.com
cdn.feathr.co
cdnjs.cloudflare.com
editor-upload-cdn.optimonk.com
eehw.net
fonts.googleapis.com
fonts.gstatic.com
front.optimonk.com
gs-cdn.optimonk.com
hansonwade.com
info.hansonwade.com
jfapiprod.optimonk.com
maps.googleapis.com
maps.gstatic.com
marco.feathr.co
match.adsrvr.org
onsite.optimonk.com
pi.pardot.com
polo.feathr.co
stats.g.doubleclick.net
tumor-myeloid-therapeutics.com
www.google-analytics.com
www.google.com
www.google.de
www.googletagmanager.com
hansonwade.com
polo.feathr.co
188.166.193.169
2400:52e0:1e00::1080:1
2400:52e0:1e00::1081:1
2400:52e0:1e00::1082:1
2606:4700:20::681a:f77
2606:4700:20::ac43:4415
2606:4700::6811:180e
2a00:1450:4001:800::2003
2a00:1450:4001:803::200a
2a00:1450:4001:80b::2003
2a00:1450:4001:80b::2004
2a00:1450:4001:80b::200e
2a00:1450:4001:80e::2008
2a00:1450:4001:828::2003
2a00:1450:4001:829::200a
2a00:1450:400c:c06::9d
3.215.172.219
34.117.177.207
34.237.219.119
35.71.131.137
5.134.13.35
65.9.66.43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